Unnamed: 0.1,Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
67000,67000,,,14654010,[],CHEMBL3268246,"Tmax in human at 500 mg, po by HPLC-ESIMS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Hour,2100573,=,1,1,=,,Tmax,hr,,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.0
67001,67001,,,14654011,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '500.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL3268247,"Cmax in human plasma assessed as demethyleneberberin at 500 mg, po by HPLC-ESIMS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Cmax,nM,,0.14,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cmax,nM,UO_0000065,,0.14
67002,67002,,,14654012,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '500.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL3268248,"Cmax in human plasma assessed as jatrorrhizine at 500 mg, po by HPLC-ESIMS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Cmax,nM,,0.13,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cmax,nM,UO_0000065,,0.13
67003,67003,,,14654013,[],CHEMBL3268624,"Tmax in human assessed as demethyleneberberin at 500 mg, po by HPLC-ESIMS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Hour,2100573,=,1,1,=,,Tmax,hr,,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.0
67004,67004,,,14654014,[],CHEMBL3268625,"Tmax in human assessed as jatrorrhizine at 500 mg, po by HPLC-ESIMS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Hour,2100573,=,1,1,=,,Tmax,hr,,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,2.0
67005,67005,,,14654015,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '500.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL3268626,"Cmax in human plasma assessed as berberrubine at 500 mg, po after 4 hrs by HPLC-ESIMS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Cmax,nM,,1.4,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cmax,nM,UO_0000065,,1.4
67006,67006,,,14654016,[],CHEMBL3268627,"Plasma concentration in human assessed as berberrubine at 500 mg, po after 24 hrs by HPLC-ESIMS/MS analysis",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,0,=,,Cp,nM,,0.15,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Cp,nM,UO_0000065,,0.15
67007,67007,,,14654017,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '15.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '15.0'}]",CHEMBL3268628,Cmax at steady state in hypercholesterolemic patient at 15 mg/kg administered for 3 months by HPLC-ESIMS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Cmax,nM,,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmaxss,nM,UO_0000065,,4.0
67008,67008,,,14654018,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '15.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '15.0'}]",CHEMBL3268629,Cmax at steady state in hypercholesterolemic patient assessed as berberrubine at 15 mg/kg/day administered for 3 months by HPLC-ESIMS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Cmax,nM,,6.7,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmaxss,nM,UO_0000065,,6.7
67009,67009,,,14654019,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '15.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '15.0'}]",CHEMBL3268630,Cmax at steady state in hypercholesterolemic patient assessed as demethyleneberberin at 15 mg/kg/day administered for 3 months by HPLC-ESIMS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Cmax,nM,,1.7,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmaxss,nM,UO_0000065,,1.7
67010,67010,,,14654020,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '15.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '15.0'}]",CHEMBL3268631,Cmax at steady state in hypercholesterolemic patient assessed as jatrorrhizine at 15 mg/kg/day administered for 3 months by HPLC-ESIMS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2100573,=,1,1,=,,Cmax,nM,,5.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmaxss,nM,UO_0000065,,5.6
67011,67011,,Active,14654021,[],CHEMBL3268632,Hypolipidemic activity in hypercholesterolemic patient assessed as reduction of total cholesterol level at 15 mg/kg/day administered for 3 months measured every month during compound treatment,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
67012,67012,,Active,14654022,[],CHEMBL3268633,Hypolipidemic activity in hypercholesterolemic patient assessed as reduction of LDL cholesterol level at 15 mg/kg/day administered for 3 months measured every month during compound treatment,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
67013,67013,,Not Active,14654023,[],CHEMBL3268634,Effect on total triglyceride level in hypercholesterolemic patient at 15 mg/kg/day administered for 3 months measured every month during compound treatment,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
67014,67014,,Not Active,14654024,[],CHEMBL3268635,Effect on HDL cholesterol level in hypercholesterolemic patient at 15 mg/kg/day administered for 3 months measured every month during compound treatment,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
67015,67015,,,14654028,[],CHEMBL3268637,"Dissociation constant, acidic pKa of the compound",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,0,=,,pKa,,,2.47,CHEMBL2362975,,No relevant target,,,,pKa,,,,2.47
67016,67016,,,14654029,[],CHEMBL3268638,"Dissociation constant, basic pKa of the compound",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3259696,J Nat Prod,2014.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2100573,=,1,0,=,,pKa,,,15.7,CHEMBL2362975,,No relevant target,,,,pKa,,,,15.7
67017,67017,,,14927354,[],CHEMBL3391286,Cytotoxicity against human U937 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3390843,Medchemcomm,2011.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.46,0,http://www.openphacts.org/units/Nanomolar,2173547,=,1,1,=,,IC50,nM,,35000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,uM,UO_0000065,,35.0
67018,67018,,,15171929,[],CHEMBL3405570,"Thermodynamic equilibrium solubility, log S of the compound in water at RT after 4 hrs by 96 well plate method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2285510,=,1,0,=,,-log(solubility),,,3.67,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,3.67
67019,67019,,,15171983,[],CHEMBL3405571,"Thermodynamic equilibrium solubility, log S of the compound in PBS at pH 7.4 at RT after 4 hrs by 96 well plate method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2285510,=,1,0,=,,-log(solubility),,,4.67,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,4.67
67020,67020,,,15172034,[],CHEMBL3405572,"Thermodynamic equilibrium solubility, log S of the compound in simulated gastric fluid at pH 1.2 at RT after 4 hrs by 96 well plate method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2285510,=,1,0,=,,-log(solubility),,,4.47,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,4.47
67021,67021,,,15172954,[],CHEMBL3405573,"Thermodynamic equilibrium solubility, log S of the compound in simulated intestinal fluid at pH 6.8 at RT after 4 hrs by 96 well plate method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2285510,=,1,0,=,,-log(solubility),,,3.4,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,3.4
67022,67022,,Not Determined,15173005,[],CHEMBL3405574,"Thermodynamic equilibrium solubility, log S of the compound in water at RT after 24 hrs by shake-flask method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2285510,,1,0,,,-log(solubility),,,,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,
67023,67023,,Not Determined,15173056,[],CHEMBL3405575,"Thermodynamic equilibrium solubility, log S of the compound PBS at pH 7.4 at RT after 24 hrs by shake-flask method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2285510,,1,0,,,-log(solubility),,,,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,
67024,67024,,Not Determined,15173107,[],CHEMBL3405576,"Thermodynamic equilibrium solubility, log S of the compound simulated gastric fluid at pH 1.2 at RT after 24 hrs by shake-flask method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2285510,,1,0,,,-log(solubility),,,,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,
67025,67025,,Not Determined,15173158,[],CHEMBL3405577,"Thermodynamic equilibrium solubility, log S of the compound simulated intestinal fluid at pH 6.8 at RT after 24 hrs by shake-flask method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2285510,,1,0,,,-log(solubility),,,,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,
67026,67026,,,15173208,[],CHEMBL3405578,"Thermodynamic equilibrium solubility, log S of the compound",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2285510,=,1,0,=,,-log(solubility),,,3.27,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,3.27
67027,67027,,inconclusive,15499583,[],CHEMBL3562077,PubChem BioAssay. High Throughput Screening for Foot and Mouth Disease Virus Antivirals.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1042837,,7,1,,,Potency,nM,,12589.3,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,12.5893
67028,67028,,inactive,15509355,[],CHEMBL3562119,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2044072,,7,1,,,AC50,nM,,2818.4,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,2.8184
67029,67029,,inactive,15513107,[],CHEMBL3562120,PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2044072,&amp;gt;,7,1,,,IC50,nM,,10000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,10.0
67030,67030,,inconclusive,15521793,[],CHEMBL3562077,PubChem BioAssay. High Throughput Screening for Foot and Mouth Disease Virus Antivirals.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,1264003,,7,1,,,Potency,nM,,12589.3,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,12.5893
67031,67031,,inactive,15539413,[],CHEMBL3562024,PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2044072,&amp;gt;,7,1,,,IC50,nM,,10000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,10.0
67032,67032,,inactive,15543064,[],CHEMBL3562026,PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2044072,&amp;gt;,7,1,,,IC50,nM,,10000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,10.0
67033,67033,,inactive,15543807,[],CHEMBL3562064,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,2044072,,7,0,,,Ac50,uM,,3.162,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,3.16227766
67034,67034,,active,15572762,[],CHEMBL3562063,PubChem BioAssay. Leishmania major promastigote EC50 determinations.   (Class of assay: confirmatory) ,F,,,BAO_0000188,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,6.36,0,http://www.openphacts.org/units/Nanomolar,1042837,=,7,1,=,,EC50,nM,,433.0,CHEMBL612545,,Unchecked,,,,EC50,uM,UO_0000065,,0.433
67035,67035,,inactive,15575104,[],CHEMBL3561990,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,2044072,,7,0,,,Ac50,uM,,2.818,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,2.818382931
67036,67036,,active,15579573,[],CHEMBL3562043,PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.57,0,http://www.openphacts.org/units/Nanomolar,2044072,=,7,1,=,,IC50,nM,,2681.5,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,2.6815
67037,67037,,inactive,15582518,[],CHEMBL3561991,PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2044072,&amp;gt;,7,1,,,IC50,nM,,10000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,10.0
67038,67038,,inactive,15592900,[],CHEMBL3562139,PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2044072,&amp;gt;,7,1,,,IC50,nM,,10000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,10.0
67039,67039,,inactive,15595789,[],CHEMBL3562152,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,2044072,,7,0,,,Ac50,uM,,3.162,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,3.16227766
67040,67040,,inactive,15598076,[],CHEMBL3562136,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2044072,,7,1,,,AC50,nM,,3162.3,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,3.1623
67041,67041,,inactive,15598806,[],CHEMBL3562146,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1201862,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2044072,,7,1,,,AC50,nM,,3162.3,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,3.1623
67042,67042,,,15733635,[],CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2503480,>,1,1,>,,IC50,nM,,20000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,uM,UO_0000065,,20.0
67043,67043,,,15733656,[],CHEMBL3625191,Cytotoxicity against rat C6 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,2503480,>,1,1,>,,IC50,nM,,20000.0,CHEMBL614657,Rattus norvegicus,C6,10116.0,,,IC50,uM,UO_0000065,,20.0
67044,67044,,,15733667,[],CHEMBL3625190,"n-octanol/water partition coefficient, log P of the compound by HPLC analysis",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2503480,=,1,1,=,,LogP,,,-1.68,CHEMBL2362975,,No relevant target,,,,logP,,,,-1.68
67045,67045,,Active,15733732,[],CHEMBL3625320,Antimigratory activity in rat C6 cells at 5 uM after 24 hrs by Transwell assay,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2503480,,1,0,,,Activity,,,,CHEMBL614657,Rattus norvegicus,C6,10116.0,,,Activity,,,,
67046,67046,,Active,15733733,[],CHEMBL3625321,Antiinvasive activity in rat C6 cells at 5 uM after 24 hrs by Transwell assay,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2503480,,1,0,,,Activity,,,,CHEMBL614657,Rattus norvegicus,C6,10116.0,,,Activity,,,,
67047,67047,,Active,15733734,[],CHEMBL3625322,Antimigratory activity in human U87 cells at 5 uM after 24 hrs by Transwell assay,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2503480,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
67048,67048,,Active,15733735,[],CHEMBL3625323,Antiinvasive activity in human U87 cells at 5 uM after 24 hrs by Transwell assay,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2503480,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
67049,67049,,Active,15733738,[],CHEMBL3625326,Drug uptake in mitochondria of rat C6 cells at 1 uM after 24 hrs by Mitotracker Green FM staining-based laser confocal microscopic analysis,A,,,BAO_0000179,BAO_0000252,mitochondrion format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2503480,,1,0,,,Drug uptake,,,,CHEMBL612558,,ADMET,,,,Drug uptake,,,,
67050,67050,,Active,15733743,[],CHEMBL3625327,Drug uptake in mitochondria of human U87 cells at 1 uM after 24 hrs by Mitotracker Green FM staining-based laser confocal microscopic analysis,A,,,BAO_0000179,BAO_0000252,mitochondrion format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2503480,,1,0,,,Drug uptake,,,,CHEMBL612558,,ADMET,,,,Drug uptake,,,,
67051,67051,,Not Active,15733748,[],CHEMBL3625328,Induction of intracellular reactive oxygen species formation in rat C6 cells at 2 uM after 24 hrs by DHE dye-based inverted fluorescent microscopic analysis,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2503480,,1,0,,,Activity,,,,CHEMBL614657,Rattus norvegicus,C6,10116.0,,,Activity,,,,
67052,67052,,Not Active,15733757,[],CHEMBL3625329,Induction of intracellular reactive oxygen species formation in human U87 cells at 2 uM after 24 hrs by DHE dye-based inverted fluorescent microscopic analysis,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3621056,Medchemcomm,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,2503480,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67053,67053,,,16391285,[],CHEMBL3736750,Inhibition of Staphylococcus aureus ATCC 6538p recombinant SrtA after 1 hr by spectrometery using Dabcyl-QALPETGEE-Edans as substrate,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3734681,J Med Chem,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2735558,=,1,1,=,,IC50,ug.mL-1,,8.7,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,8.7
67054,67054,,,16423860,[],CHEMBL3751354,Inhibition of Staphylococcus aureus ATCC 6538p sortase A expressed in Escherichia coli using dabcyl-QALPETGEE-edans as substrate incubated for 1 hr by fluorescence spectrophotometry analysis,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3745680,J Nat Prod,2015.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2740839,=,1,1,=,,IC50,ug.mL-1,,40.6,CHEMBL5362,Staphylococcus aureus,Sortase A,1280.0,,,IC50,ug ml-1,UO_0000274,,40.6
67055,67055,,,16588789,[],CHEMBL3807947,Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay relative to control,A,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3804798,Medchemcomm,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,2777985,=,1,0,=,,Activity,%,,97.2,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,Activity,%,UO_0000187,,97.2
67056,67056,,,16588807,[],CHEMBL3807949,Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO release at 5 uM after 24 hrs by Griess assay relative to control,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3804798,Medchemcomm,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,2777985,=,1,1,=,,Inhibition,%,,21.1,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,INH,%,UO_0000187,,21.1
67057,67057,,,16588855,[],CHEMBL3807948,Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 5 uM after 48 hrs by MTT assay relative to control,A,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3804798,Medchemcomm,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,2777985,=,1,0,=,,Activity,%,,99.4,CHEMBL612557,Mus musculus,RAW264.7,10090.0,,,Activity,%,UO_0000187,,99.4
67058,67058,,,16782556,[],CHEMBL3865867,Antimicrobial activity against vancomycin-sensitive Enterococcus faecalis after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3865781,Bioorg Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2805845,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,16.0,4.0
67059,67059,,,16782575,[],CHEMBL3865866,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3865781,Bioorg Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2805845,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,16.0,4.0
67060,67060,,,16782594,[],CHEMBL3865856,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA-41 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3865781,Bioorg Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2805845,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,8.0,2.0
67061,67061,,,16782634,[],CHEMBL3865855,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3865781,Bioorg Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2805845,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,128.0,32.0
67062,67062,,,16782653,[],CHEMBL3865868,Antibacterial activity against Klebsiella pneumoniae ATCC BAA-1144 after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3865781,Bioorg Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2805845,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,128.0,32.0
67063,67063,,,16782672,[],CHEMBL3865869,Antibacterial activity against methicillin-sensitive Staphylococcus aureus after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3865781,Bioorg Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2805845,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,8.0,2.0
67064,67064,,,16782684,[],CHEMBL3865870,Inhibition of recombinant Escherichia coli K12 FtsZ assembly by light-scattering assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3865781,Bioorg Med Chem,2016.0,"{'bei': '14.86', 'le': '0.27', 'lle': '1.90', 'sei': '12.25'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.0,0,http://www.openphacts.org/units/Nanomolar,2805845,=,1,1,=,,IC50,nM,,10000.0,CHEMBL3999,Escherichia coli K-12,Cell division protein ftsZ,83333.0,,,IC50,uM,UO_0000065,,10.0
67065,67065,,,16782685,[],CHEMBL3865871,Inhibition of recombinant Escherichia coli K12 FtsZ GTPase activity by malachite green sodium molybdate assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL3865781,Bioorg Med Chem,2016.0,"{'bei': '14.26', 'le': '0.26', 'lle': '1.70', 'sei': '11.75'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.8,0,http://www.openphacts.org/units/Nanomolar,2805845,=,1,1,=,,IC50,nM,,16000.0,CHEMBL3999,Escherichia coli K-12,Cell division protein ftsZ,83333.0,,,IC50,uM,UO_0000065,,16.0
67066,67066,,,18115471,[],CHEMBL4025665,Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4024711,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.31,0,http://www.openphacts.org/units/Nanomolar,3004159,=,1,1,=,,IC50,nM,,49010.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,uM,UO_0000065,,49.01
67067,67067,,,18115501,[],CHEMBL4025669,Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4024711,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.59,0,http://www.openphacts.org/units/Nanomolar,3004159,=,1,1,=,,IC50,nM,,25940.0,CHEMBL613831,Homo sapiens,SMMC-7721,9606.0,,,IC50,uM,UO_0000065,,25.94
67068,67068,,,18115505,[],CHEMBL4025670,Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4024711,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.4,0,http://www.openphacts.org/units/Nanomolar,3004159,=,1,1,=,,IC50,nM,,39950.0,CHEMBL394,Homo sapiens,HCT-116,9606.0,,,IC50,uM,UO_0000065,,39.95
67069,67069,,,18115509,[],CHEMBL4025671,Cytotoxicity against human HL60 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4024711,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.56,0,http://www.openphacts.org/units/Nanomolar,3004159,=,1,1,=,,IC50,nM,,27420.0,CHEMBL383,Homo sapiens,HL-60,9606.0,,,IC50,uM,UO_0000065,,27.42
67070,67070,,,18115513,[],CHEMBL4025672,Cytotoxicity against human LO2 cells after 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4024711,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.14,0,http://www.openphacts.org/units/Nanomolar,3004159,=,1,1,=,,IC50,nM,,71550.0,CHEMBL4296457,Homo sapiens,L02,9606.0,,,IC50,uM,UO_0000065,,71.55
67071,67071,,,18248052,[],CHEMBL4053788,Antibacterial activity against Bacillus subtilis 168 after 18 hrs by Mueller-Hinton broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4052617,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028327,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,128.0
67072,67072,,,18248091,[],CHEMBL4053789,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by cation adjusted Mueller-Hinton broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4052617,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028327,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
67073,67073,,,18248130,[],CHEMBL4053790,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC BAA41 after 18 hrs by cation adjusted Mueller-Hinton broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4052617,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028327,=,1,1,=,,MIC,ug.mL-1,,192.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,192.0
67074,67074,,,18248169,[],CHEMBL4053785,Antibacterial activity against antibiotic-susceptile Enterococcus faecium ATCC 49624 after 18 hrs by brain heart infusion broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4052617,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028327,>,1,1,>,,MIC,ug.mL-1,,192.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,192.0
67075,67075,,,18248208,[],CHEMBL4053786,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 after 18 hrs by brain heart infusion broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4052617,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028327,>,1,1,>,,MIC,ug.mL-1,,192.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,192.0
67076,67076,,,18248247,[],CHEMBL4053791,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by Mueller-Hinton broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4052617,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028327,>,1,1,>,,MIC,ug.mL-1,,192.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,192.0
67077,67077,,,18248286,[],CHEMBL4053792,Antibacterial activity against Escherichia coli ATCC BAA2108 expressing NDM-1 beta-lactamase after 18 hrs by Mueller-Hinton broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4052617,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028327,>,1,1,>,,MIC,ug.mL-1,,192.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,192.0
67078,67078,,,18248325,[],CHEMBL4053793,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa ATCC BAA2108 after 18 hrs by Mueller-Hinton broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4052617,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028327,>,1,1,>,,MIC,ug.mL-1,,192.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,192.0
67079,67079,,,18248364,[],CHEMBL4053794,Antibacterial activity against Klebsiella pneumoniae ATCC BAA2470 expressing NDM-1 beta-lactamase after 18 hrs by Mueller-Hinton broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4052617,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3028327,>,1,1,>,,MIC,ug.mL-1,,192.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,192.0
67080,67080,,,18322612,[],CHEMBL4134763,Stimulation of glucose consumption in rat L6 cells at 10 uM incubated for 12 hrs by glucose assay reagent based glucose oxidase method relative to untreated control,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,173.1,CHEMBL614793,Rattus norvegicus,L6,10116.0,,,Activity,%,UO_0000187,,173.1
67081,67081,,,18322614,[],CHEMBL4134764,Inhibition of glucose production in Sprague-Dawley rat primary hepatocytes grown under gluconeogenic medium assessed as glucose production level at 5 uM incubated for 6 hrs by glucose assay reagent based glucose oxidase method (Rvb = 100%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,68.8,CHEMBL613362,Rattus norvegicus,Hepatocyte,10116.0,,,Activity,%,UO_0000187,,68.8
67082,67082,,,18322627,[],CHEMBL4134765,Inhibition of glucose production in Sprague-Dawley rat primary hepatocytes grown under gluconeogenic medium assessed as glucose production level at 10 uM incubated for 6 hrs by glucose assay reagent based glucose oxidase method (Rvb = 100%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,64.7,CHEMBL613362,Rattus norvegicus,Hepatocyte,10116.0,,,Activity,%,UO_0000187,,64.7
67083,67083,,,18322640,[],CHEMBL4134766,Inhibition of glucose production in Sprague-Dawley rat primary hepatocytes grown under gluconeogenic medium assessed as glucose production level at 20 uM incubated for 6 hrs by glucose assay reagent based glucose oxidase method (Rvb = 100%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,49.8,CHEMBL613362,Rattus norvegicus,Hepatocyte,10116.0,,,Activity,%,UO_0000187,,49.8
67084,67084,,,18322746,[],CHEMBL4134795,Inhibition of mitochondrial membranes potential in rat L6 cells assessed as mitochondrial membranes potential level at 20 uM incubated for 40 mins by JC1 dye staining based fluorescence assay (Rvb = 100 +/- 2.8%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,91.2,CHEMBL614793,Rattus norvegicus,L6,10116.0,,,Activity,%,UO_0000187,,91.2
67085,67085,,,18322756,[],CHEMBL4134796,Inhibition of oxygen consumption rate in rat L6 cells assessed as oxygen consumption level at 10 uM (Rvb = 100 +/- 1.6%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,91.9,CHEMBL614793,Rattus norvegicus,L6,10116.0,,,Activity,%,UO_0000187,,91.9
67086,67086,,,18322760,[],CHEMBL4134797,Inhibition of oxygen consumption rate in rat L6 cells assessed as oxygen consumption level at 20 uM (Rvb = 100 +/- 1.6%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,75.0,CHEMBL614793,Rattus norvegicus,L6,10116.0,,,Activity,%,UO_0000187,,75.0
67087,67087,,,18322764,[],CHEMBL4134798,Inhibition of oxygen consumption rate in isolated mitochondria from rat L6 cells assessed as oxygen consumption level at 1.2 uM (Rvb = 100 +/- 1.9%),F,,,BAO_0001103,BAO_0000252,mitochondrion format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,78.9,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,78.9
67088,67088,,,18322768,[],CHEMBL4134799,Inhibition of oxygen consumption rate in isolated mitochondria from rat L6 cells assessed as oxygen consumption level at 2.5 uM (Rvb = 100 +/- 1.9%),F,,,BAO_0001103,BAO_0000252,mitochondrion format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,69.3,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,69.3
67089,67089,,,18322772,[],CHEMBL4134800,Inhibition of oxygen consumption rate in isolated mitochondria from rat L6 cells assessed as oxygen consumption level at 5 uM (Rvb = 100 +/- 1.9%),F,,,BAO_0001103,BAO_0000252,mitochondrion format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,63.6,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,63.6
67090,67090,,,18322776,[],CHEMBL4134801,Inhibition of oxygen consumption rate in isolated mitochondria from rat L6 cells assessed as oxygen consumption level at 10 uM (Rvb = 100 +/- 1.9%),F,,,BAO_0001103,BAO_0000252,mitochondrion format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3042007,=,1,0,=,,Activity,%,,59.2,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,59.2
67091,67091,,,18322827,[],CHEMBL4134825,Inhibition of human ERG by patch clamp assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4130473,Eur J Med Chem,2017.0,"{'bei': '16.38', 'le': '0.30', 'lle': '2.41', 'sei': '13.50'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.51,0,http://www.openphacts.org/units/Nanomolar,3042007,=,1,1,=,,IC50,nM,,3100.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,uM,UO_0000065,,3.1
67092,67092,,,18578384,[],CHEMBL4222420,Activation of AMPK in differentiated Sprague-Dawley rat L6 myotube cells assessed as glucose consumption at 10 uM after 12 hrs by colorimetric assay (Rvb = 100 +/- 1.8%),B,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4219147,Bioorg Med Chem,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3085032,=,1,0,=,,Activity,%,,227.6,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,227.6
67093,67093,,,18578518,[],CHEMBL4222425,Cytotoxicity against Sprague-Dawley rat L6 cells assessed as cell viability at 10 uM after 12 hrs by SRB assay (Rvb = 100 +/- 1.8%),A,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4219147,Bioorg Med Chem,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3085032,=,1,0,=,,Activity,%,,100.3,CHEMBL614793,Rattus norvegicus,L6,10116.0,,,Activity,%,UO_0000187,,100.3
67094,67094,,,18578557,[],CHEMBL4222428,Activation of AMPK in Sprague-Dawley rat primary hepatocytes assessed as inhibition of gluconeogenesis by measuring glucose production at 5 uM after 6 hrs by colorimetric assay (Rvb = 100 +/- 3.5%),B,,,BAO_0001103,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4219147,Bioorg Med Chem,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3085032,=,1,0,=,,Activity,%,,57.6,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,57.6
67095,67095,,Active,18578605,[],CHEMBL4222434,Upregulation of AMPKalpha phosphorylation at Thr172 residues in Sprague-Dawley rat L6 myotube cells at 10 uM after 1 hr by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4219147,Bioorg Med Chem,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3085032,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67096,67096,,Active,18578606,[],CHEMBL4222435,Activation of AMPK in Sprague-Dawley rat L6 myotube cells assessed as increase in acetyl-CoA carboxylase phosphorylation at Ser79 residues at 10 uM after 1 hr by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4219147,Bioorg Med Chem,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3085032,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67097,67097,,,18578614,[],CHEMBL4222436,Inhibition of mitochondrial respiratory complex 1 in differentiated Sprague-Dawley rat L6 myotube cells assessed as mitochondrial membrane potential at 5 uM after 40 to 60 mins by JC-1 staining based fluorescence assay (Rvb = 100 +/- 1.6%),B,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4219147,Bioorg Med Chem,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3085032,=,1,0,=,,Activity,%,,91.5,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,91.5
67098,67098,,,18578624,[],CHEMBL4222437,Inhibition of mitochondrial respiratory complex 1 in differentiated Sprague-Dawley rat L6 myotube cells assessed as mitochondrial membrane potential at 10 uM after 40 to 60 mins by JC-1 staining based fluorescence assay (Rvb = 100 +/- 1.6%),B,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4219147,Bioorg Med Chem,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3085032,=,1,0,=,,Activity,%,,85.8,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,85.8
67099,67099,,,18578635,[],CHEMBL4222438,Inhibition of mitochondrial respiratory complex 1 in differentiated Sprague-Dawley rat L6 myotube cells assessed as mitochondrial membrane potential at 20 uM after 40 to 60 mins by JC-1 staining based fluorescence assay (Rvb = 100 +/- 1.6%),B,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4219147,Bioorg Med Chem,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3085032,=,1,0,=,,Activity,%,,84.5,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,84.5
67100,67100,,,18720497,[],CHEMBL4257963,Inhibition of recombinant human CYP1A1 expressed in baker's yeast-derived microsomes (Sacchrosomes) at 10 uM using 7-ethoxyresorufin substrate by EROD assay relative to control,B,,,BAO_0000201,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4257453,Medchemcomm,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3110194,=,1,1,=,,Inhibition,%,,48.0,CHEMBL2231,Homo sapiens,Cytochrome P450 1A1,9606.0,,,INH,%,UO_0000187,,48.0
67101,67101,,,18829881,[],CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4303101,,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3136379,=,52,1,=,,Inhibition,%,,1.59,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition,%,UO_0000187,,1.59
67102,67102,,,19107587,[],CHEMBL4369784,Cytotoxicity against human HepG2 cells after 12 hrs by CCK-8 assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4368899,Medchemcomm,2019.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3188161,=,1,1,=,,IC50,ug.mL-1,,53.91,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,ug ml-1,UO_0000274,,53.91
67103,67103,,,19107594,[],CHEMBL4369785,Stability of compound in acetonitrile/water at 1:1 ratio at pH 1.5 assessed as compound degradation after 5 hrs by HPLC analysis,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4368899,Medchemcomm,2019.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3188161,=,1,0,=,,Drug degradation,%,,1.8,CHEMBL2362975,,No relevant target,,,,Drug degradation,%,UO_0000187,,1.8
67104,67104,,,19107596,[],CHEMBL4369786,Aqueous solubility of compound,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4368899,Medchemcomm,2019.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3188161,=,1,1,=,,Solubility,ug.mL-1,,1750.0,CHEMBL2362975,,No relevant target,,,,solubility,mg/ml,UO_0000274,,1.75
67105,67105,,,19284786,[],CHEMBL4409751,Increase in glucose consumption in human HepG2 cells assessed as glucose content in medium at 10'-6 M measured after 24 hrs by glucose oxidase method relative to control,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4406871,Bioorg Med Chem Lett,2019.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3220385,=,1,0,=,,Activity,%,,5.16,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,%,UO_0000187,,5.16
67106,67106,,,19284802,[],CHEMBL4409759,Oral bioavailability in rat,A,,,BAO_0003042,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4406871,Bioorg Med Chem Lett,2019.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3220385,<,1,1,<,,F,%,,1.0,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,1.0
67107,67107,,,19304592,[],CHEMBL4414411,Inhibition of Staphylococcus aureus SrtA using dabcyl-QALPETGEE-edans as substrate preincubated for 1 hr followed by substrate addition and measured at 1 min interval for 1 hr by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4411342,Bioorg Med Chem,2019.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3223505,=,1,1,=,,IC50,nM,,120000.0,CHEMBL5362,Staphylococcus aureus,Sortase A,1280.0,,,IC50,uM,UO_0000065,,120.0
67108,67108,,,19426833,[],CHEMBL4428171,Inhibition of Escherichia coli FtsZ assessed as reduction in polymerization,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428024,J Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,3245018,=,1,0,=,,INH,uM,,10.0,CHEMBL3999,Escherichia coli K-12,Cell division protein ftsZ,83333.0,,,INH,uM,UO_0000064,,10.0
67109,67109,,,19426835,[],CHEMBL4428172,Inhibition of Escherichia coli FtsZ assessed as reduction in GTPase activity by malachite green assay,B,,,BAO_0000179,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428024,J Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,3245018,=,1,0,=,,INH,uM,,16.0,CHEMBL3999,Escherichia coli K-12,Cell division protein ftsZ,83333.0,,,INH,uM,UO_0000064,,16.0
67110,67110,,,19426838,[],CHEMBL4428173,Antimicrobial activity against Bacillus subtilis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428024,J Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245018,=,1,0,=,,INH,ug ml-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,ug ml-1,UO_0000274,,100.0
67111,67111,,,19426843,[],CHEMBL4428174,Antimicrobial activity against Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428024,J Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245018,=,1,0,=,,INH,ug ml-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,INH,ug ml-1,UO_0000274,128.0,32.0
67112,67112,,,19426849,[],CHEMBL4428175,Antimicrobial activity against Escherichia coli,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428024,J Med Chem,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Micromolar,3245018,>,1,0,>,,INH,uM,,400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,INH,uM,UO_0000064,,400.0
67113,67113,,,19426853,[],CHEMBL4428176,Displacement of bis-ANS from Escherichia coli FtsZ,B,,,BAO_0000034,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428024,J Med Chem,2016.0,"{'bei': '22.71', 'le': '0.42', 'lle': '4.54', 'sei': '18.72'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,7.64,0,http://www.openphacts.org/units/Nanomolar,3245018,=,1,1,=,,Kd,nM,,23.0,CHEMBL3999,Escherichia coli K-12,Cell division protein ftsZ,83333.0,,,Kd,uM,UO_0000065,,0.023
67114,67114,,,19428178,[],CHEMBL4428443,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
67115,67115,,,19428192,[],CHEMBL4428439,Antimicrobial activity against Eberthella typhosa ATCC 14028 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,512.0
67116,67116,,,19428206,[],CHEMBL4428440,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
67117,67117,,,19428220,[],CHEMBL4428442,Antimicrobial activity against Bacillus proteus ATCC13315 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL4296593,Proteus hauseri,Proteus hauseri,183417.0,,,MIC,ug ml-1,UO_0000274,,256.0
67118,67118,,,19428233,[],CHEMBL4428441,Antimicrobial activity against Escherichia coli JM109 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
67119,67119,,,19428238,[],CHEMBL4428444,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
67120,67120,,,19428252,[],CHEMBL4428445,Antimicrobial activity against Bacillus subtilis ATCC 6633 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,512.0
67121,67121,,,19428266,[],CHEMBL4428446,Antimicrobial activity against Micrococcus luteus ATCC 4698 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,512.0
67122,67122,,,19428280,[],CHEMBL4428447,Antimicrobial activity against Candida utilis ATCC 9950 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC80,ug.mL-1,,256.0,CHEMBL612309,Cyberlindnera jadinii,Cyberlindnera jadinii,4903.0,,,MIC80,ug ml-1,UO_0000274,,256.0
67123,67123,,,19428294,[],CHEMBL4428448,Antimicrobial activity against Aspergillus flavus ATCC 204304 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC80,ug.mL-1,,512.0,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,,MIC80,ug ml-1,UO_0000274,,512.0
67124,67124,,,19428308,[],CHEMBL4428449,Antimicrobial activity against beer yeast ATCC 9763 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC80,ug.mL-1,,128.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC80,ug ml-1,UO_0000274,,128.0
67125,67125,,,19428322,[],CHEMBL4428450,Antimicrobial activity against Candida albicans ATCC 76615 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC80,ug.mL-1,,512.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC80,ug ml-1,UO_0000274,,512.0
67126,67126,,,19428336,[],CHEMBL4428451,Antimicrobial activity against Candida mycoderma ATCC 9888 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245238,=,1,1,=,,MIC80,ug.mL-1,,128.0,CHEMBL612545,,Unchecked,,,,MIC80,ug ml-1,UO_0000274,,128.0
67127,67127,,Toxic,19428350,[],CHEMBL4428452,Cytotoxicity against human HepG2 cells assessed as cell viability at 6.25 to 100 ug/ml by MTT assay,A,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3245238,,1,0,,,Activity,,,,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,,,,
67128,67128,,,19960351,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4495564,,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3346769,=,52,1,=,,Inhibition,%,,18.85,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,18.85099789
67129,67129,,,20150825,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4495565,,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3364641,=,52,1,=,,Inhibition,%,,-0.07,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.07
67130,67130,,,20601246,[],CHEMBL4603715,Antiproliferative activity against human PC3 cells assessed as cell growth inhibition by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4602631,Bioorg Med Chem Lett,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.84,0,http://www.openphacts.org/units/Nanomolar,3465479,=,1,1,=,,IC50,nM,,14390.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,IC50,uM,UO_0000065,,14.39
67131,67131,,,20601261,[],CHEMBL4603716,Antiproliferative activity against human DU145 cells assessed as cell growth inhibition by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4602631,Bioorg Med Chem Lett,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3465479,>,1,1,>,,IC50,nM,,20000.0,CHEMBL613508,Homo sapiens,DU-145,9606.0,,,IC50,uM,UO_0000065,,20.0
67132,67132,,,20601276,[],CHEMBL4603717,Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4602631,Bioorg Med Chem Lett,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.69,0,http://www.openphacts.org/units/Nanomolar,3465479,=,1,1,=,,IC50,nM,,20600.0,CHEMBL400,Homo sapiens,MDA-MB-231,9606.0,,,IC50,uM,UO_0000065,,20.6
67133,67133,,,20601291,[],CHEMBL4603718,Antiproliferative activity against human HCT116 cells assessed as cell growth inhibition by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4602631,Bioorg Med Chem Lett,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3465479,>,1,1,>,,IC50,nM,,10000.0,CHEMBL394,Homo sapiens,HCT-116,9606.0,,,IC50,uM,UO_0000065,,10.0
67134,67134,,,20601306,[],CHEMBL4603719,Antiproliferative activity against human HT-29 cells assessed as cell growth inhibition by SRB assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4602631,Bioorg Med Chem Lett,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3465479,>,1,1,>,,IC50,nM,,10000.0,CHEMBL384,Homo sapiens,HT-29,9606.0,,,IC50,uM,UO_0000065,,10.0
67135,67135,,,20601316,[],CHEMBL4603720,Cytotoxicity against human HAF cells assessed as cell growth inhibition by SRB assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4602631,Bioorg Med Chem Lett,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.07,0,http://www.openphacts.org/units/Nanomolar,3465479,=,1,1,=,,IC50,nM,,86120.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,86.12
67136,67136,,,20601326,[],CHEMBL4603721,"Selectivity index, ratio of IC50 for cytotoxicity against human HAF cells assessed as cell growth inhibition by SRB assay to IC50 for antiproliferative activity against human PC3 cells assessed as cell growth inhibition by SRB assay",T,,,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4602631,Bioorg Med Chem Lett,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3465479,=,1,0,=,,Ratio IC50,,,6.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,6.0
67137,67137,,Not Active,20601345,[],CHEMBL4603735,Induction of cell morphological changes in human PC3 cells assessed as cytoplasmic vacuolization at 50 uM measured after 24 hrs by white light microscopy,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4602631,Bioorg Med Chem Lett,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3465479,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
67138,67138,,,20604342,[],CHEMBL4604493,Inhibition of Staphylococcus aureus sortase A,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4602663,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3466116,=,1,1,=,,IC50,nM,,102000.0,CHEMBL5362,Staphylococcus aureus,Sortase A,1280.0,,,IC50,uM,UO_0000065,,102.0
67139,67139,,,20649423,[],CHEMBL4615295,Inhibition of cell proliferation of human KM12C cells incubated for 15 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.12,0,http://www.openphacts.org/units/Nanomolar,3475880,=,1,1,=,,IC50,nM,,76340.0,CHEMBL4632329,Homo sapiens,KM12C,9606.0,,,IC50,uM,UO_0000065,,76.34
67140,67140,,Active,20649425,[],CHEMBL4615296,Activation of RXRalpha LBD (unknown origin) expressed in human KM12C cells at 50 uM incubated for 15 hrs by luciferase reporter gene assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67141,67141,,Not Active,20649427,[],CHEMBL4615297,Activation of RXRalpha R371S mutant LBD (unknown origin) expressed in human KM12C cells at 50 uM incubated for 15 hrs by luciferase reporter gene assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67142,67142,,,20649429,[],CHEMBL4615298,Inhibition of cell proliferation of human HCT116 cells incubated for 15 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.08,0,http://www.openphacts.org/units/Nanomolar,3475880,=,1,1,=,,IC50,nM,,83090.0,CHEMBL394,Homo sapiens,HCT-116,9606.0,,,IC50,uM,UO_0000065,,83.09
67143,67143,,,20649431,[],CHEMBL4615299,Inhibition of cell proliferation of human SW620 cells incubated for 15 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3475880,=,1,1,=,,IC50,nM,,126200.0,CHEMBL612262,Homo sapiens,SW-620,9606.0,,,IC50,uM,UO_0000065,,126.2
67144,67144,,,20649443,[],CHEMBL4615310,Binding affinity to His-tagged RXRalpha LBD (unknown origin) expressed in Escherichia coli strain BL21 (DE3) by fluorescence quenching analysis,B,,,BAO_0000034,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,"{'bei': '13.69', 'le': '0.25', 'lle': '1.51', 'sei': '11.29'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.61,0,http://www.openphacts.org/units/Nanomolar,3475880,=,1,1,=,,Kd,nM,,24800.0,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Kd,10'-5M,UO_0000065,,2.48
67145,67145,,Active,20649445,[],CHEMBL4615311,Induction of conformational changes in His-tagged RXRalpha LBD (unknown origin) expressed in Escherichia coli strain BL21 (DE3) at 5 uM by circular dichroism spectroscopic assay,B,,,BAO_0000375,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67146,67146,,Active,20649447,[],CHEMBL4615312,Activation of RXRalpha in human KM12C cells assessed as inhibition of Wnt/beta-catenin-dependent transcriptional activity at 25 to 50 uM incubated for 15 hrs by TOP/FOP luciferase assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67147,67147,,Active,20649449,[],CHEMBL4615313,Activation of RXRalpha in human HCT116 cells assessed as inhibition of Wnt/beta-catenin-dependent transcriptional activity at 30 to 60 uM incubated for 15 hrs by TOP/FOP luciferase assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67148,67148,,Active,20649451,[],CHEMBL4615314,Activation of RXRalpha in human SW620 cells assessed as inhibition of Wnt/beta-catenin-dependent transcriptional activity at 40 to 80 uM incubated for 15 hrs by TOP/FOP luciferase assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67149,67149,,Active,20649453,[],CHEMBL4615315,Activation of RXRalpha in human KM12C cells assessed as induction of beta-catenin protein degradation at 25 to 50 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67150,67150,,Active,20649455,[],CHEMBL4615316,Activation of RXRalpha in human HCT116 cells assessed as induction of beta-catenin protein degradation at 30 to 60 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67151,67151,,Active,20649457,[],CHEMBL4615317,Activation of RXRalpha in human SW620 cells assessed as induction of beta-catenin protein degradation at 40 to 80 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67152,67152,,Active,20649459,[],CHEMBL4615318,Activation of RXRalpha (unknown origin) expressed in human KM12C cells co-expressing beta-catenin assessed as induction of RXRalpha interaction with beta-catenin at 25 to 50 uM incubated for 15 hrs by mammalian two-hybrid assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67153,67153,,Active,20649461,[],CHEMBL4615319,Activation of RXRalpha (unknown origin) expressed in human HCT116 cells co-expressing beta-catenin assessed as induction of RXRalpha interaction with beta-catenin at 30 to 60 uM incubated for 15 hrs by mammalian two-hybrid assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67154,67154,,Active,20649463,[],CHEMBL4615320,Activation of RXRalpha (unknown origin) expressed in human SW620 cells co-expressing beta-catenin assessed as induction of RXRalpha interaction with beta-catenin at 40 to 80 uM incubated for 15 hrs by mammalian two-hybrid assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67155,67155,,Active,20649465,[],CHEMBL4615321,Activation of RXRalpha (unknown origin) expressed in human KM12C cells co-expressing beta-catenin and c-Cbl assessed as induction of beta-caten interaction with c-Cbl at 25 to 50 uM incubated for 15 hrs by mammalian two-hybrid assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67156,67156,,Active,20649467,[],CHEMBL4615322,Activation of RXRalpha (unknown origin) expressed in human HCT116 cells co-expressing beta-catenin and c-Cbl assessed as induction of beta-caten interaction with c-Cbl at 30 to 60 uM incubated for 15 hrs by mammalian two-hybrid assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67157,67157,,Active,20649469,[],CHEMBL4615323,Activation of RXRalpha (unknown origin) expressed in human SW620 cells co-expressing beta-catenin and c-Cbl assessed as induction of beta-caten interaction with c-Cbl at 40 to 80 uM incubated for 15 hrs by mammalian two-hybrid assay,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67158,67158,,Active,20649471,[],CHEMBL4615324,Activation of RXRalpha in human KM12C cells assessed as reduction in Cdc2 protein expression at 25 to 50 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67159,67159,,Active,20649473,[],CHEMBL4615325,Activation of RXRalpha in human KM12C cells assessed as reduction in Cdc2 mRNA expression at 25 to 50 uM incubated for 15 hrs by real-time PCR analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67160,67160,,Active,20649475,[],CHEMBL4615326,Activation of RXRalpha in human KM12C cells assessed as reduction in c-Myc protein expression at 25 to 50 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67161,67161,,Active,20649477,[],CHEMBL4615327,Activation of RXRalpha in human KM12C cells assessed as reduction in c-Myc mRNA expression at 25 to 50 uM incubated for 15 hrs by real-time PCR analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67162,67162,,Active,20649479,[],CHEMBL4615328,Activation of RXRalpha in human KM12C cells assessed as increase in p21 (WAF1/CIP1) protein expression at 25 to 50 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67163,67163,,Active,20649481,[],CHEMBL4615329,Activation of RXRalpha in human KM12C cells assessed as reduction in crease in p21 (WAF1/CIP1) mRNA expression at 25 to 50 uM incubated for 15 hrs by real-time PCR analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67164,67164,,Active,20649483,[],CHEMBL4615330,Activation of RXRalpha in human HCT116 cells assessed as reduction in Cdc2 protein expression at 30 to 60 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67165,67165,,Active,20649485,[],CHEMBL4615331,Activation of RXRalpha in human HCT116 cells assessed as reduction in Cdc2 mRNA expression at 30 to 60 uM incubated for 15 hrs by real-time PCR analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67166,67166,,Active,20649487,[],CHEMBL4615332,Activation of RXRalpha in human HCT116 cells assessed as reduction in c-Myc protein expression at 30 to 60 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67167,67167,,Active,20649489,[],CHEMBL4615333,Activation of RXRalpha in human HCT116 cells assessed as reduction in c-Myc mRNA expression at 30 to 60 uM incubated for 15 hrs by real-time PCR analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67168,67168,,Active,20649491,[],CHEMBL4615334,Activation of RXRalpha in human HCT116 cells assessed as increase in p21 (WAF1/CIP1) protein expression at 30 to 60 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67169,67169,,Active,20649493,[],CHEMBL4615335,Activation of RXRalpha in human HCT116 cells assessed as reduction in crease in p21 (WAF1/CIP1) mRNA expression at 30 to 60 uM incubated for 15 hrs by real-time PCR analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67170,67170,,Active,20649495,[],CHEMBL4615336,Activation of RXRalpha in human SW620 cells assessed as reduction in Cdc2 protein expression at 40 to 80 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67171,67171,,Active,20649497,[],CHEMBL4615337,Activation of RXRalpha in human SW620 cells assessed as reduction in Cdc2 mRNA expression at 40 to 80 uM incubated for 15 hrs by real-time PCR analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67172,67172,,Active,20649499,[],CHEMBL4615338,Activation of RXRalpha in human SW620 cells assessed as reduction in c-Myc protein expression at 40 to 80 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67173,67173,,Active,20649501,[],CHEMBL4615339,Activation of RXRalpha in human SW620 cells assessed as reduction in c-Myc mRNA expression at 40 to 80 uM incubated for 15 hrs by real-time PCR analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67174,67174,,Active,20649503,[],CHEMBL4615340,Activation of RXRalpha in human SW620 cells assessed as increase in p21 (WAF1/CIP1) protein expression at 40 to 80 uM incubated for 15 hrs by Western blot analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67175,67175,,Active,20649505,[],CHEMBL4615341,Activation of RXRalpha in human SW620 cells assessed as reduction in crease in p21 (WAF1/CIP1) mRNA expression at 40 to 80 uM incubated for 15 hrs by real-time PCR analysis,B,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67176,67176,,,20649514,[],CHEMBL4615349,"Antitumor activity against human KM12C cells xenografted in BALB/c mouse assessed as inhibition of tumor growth at 100 mg/kg, ig dosed daily for 15 days relative to control",F,,,BAO_0000194,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3475880,=,1,0,=,,TGI,%,,33.6,CHEMBL4632329,Homo sapiens,KM12C,9606.0,,,TGI,%,UO_0000187,,33.6
67177,67177,,Active,20649516,[],CHEMBL4615294,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as induction of beta-catenin protein degradation at 100 mg/kg, ig dosed daily for 15 days by Western blot analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67178,67178,,Active,20649518,[],CHEMBL4615350,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as reduction in Cdc2 protein expression at 100 mg/kg, ig dosed daily for 15 days by Western blot analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67179,67179,,Active,20649520,[],CHEMBL4615351,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as reduction in c-Myc protein expression at 100 mg/kg, ig dosed daily for 15 days by Western blot analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67180,67180,,Active,20649522,[],CHEMBL4615352,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as increase in p21 (WAF1/CIP) protein expression at 100 mg/kg, ig dosed daily for 15 days by Western blot analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67181,67181,,Active,20649524,[],CHEMBL4615353,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as induction of beta-catenin protein degradation at 100 mg/kg, ig dosed daily for 15 days by immunohistochemistry analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67182,67182,,Active,20649526,[],CHEMBL4615354,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as reduction in Cdc2 protein expression at 100 mg/kg, ig dosed daily for 15 days by immunohistochemistry analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67183,67183,,Active,20649528,[],CHEMBL4615355,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as reduction in c-Myc protein expression at 100 mg/kg, ig dosed daily for 15 days by immunohistochemistry analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67184,67184,,Active,20649530,[],CHEMBL4615356,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as effect on PCNA protein expression at 100 mg/kg, ig dosed daily for 15 days by immunohistochemistry analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67185,67185,,Active,20649532,[],CHEMBL4615357,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as effect on Ki67 protein expression at 100 mg/kg, ig dosed daily for 15 days by immunohistochemistry analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67186,67186,,Active,20649534,[],CHEMBL4615358,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as increase in p21 (WAF1/CIP) protein expression at 100 mg/kg, ig dosed daily for 15 days by immunohistochemistry analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67187,67187,,Active,20649536,[],CHEMBL4615359,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as reduction in Cdc2 mRNA expression at 100 mg/kg, ig dosed daily for 15 days by real-time PCR analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67188,67188,,Active,20649538,[],CHEMBL4615360,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as reduction in c-Myc mRNA expression at 100 mg/kg, ig dosed daily for 15 days by real-time PCR analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67189,67189,,Active,20649540,[],CHEMBL4615361,"In-vivo activation of RXRalpha in BALB/c mouse xenografted with human KM12C cells assessed as increase in p21 (WAF1/CIP1) mRNA expression at 100 mg/kg, ig dosed daily for 15 days by real-time PCR analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,,1,0,,,Activity,,,,CHEMBL2061,Homo sapiens,Retinoid X receptor alpha,9606.0,,,Activity,,,,
67190,67190,,,20649547,[],CHEMBL4615367,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring TBIL level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 0.28 +/- 0.024 umol/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,umol/L,,0.26,CHEMBL612558,,ADMET,,,,Activity,umol/L,,,0.26
67191,67191,,,20649549,[],CHEMBL4615368,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring IBIL level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 0.55 +/- 0.096 umol/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,umol/L,,0.4,CHEMBL612558,,ADMET,,,,Activity,umol/L,,,0.4
67192,67192,,,20649551,[],CHEMBL4615369,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring ALT level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 24.18 +/- 0.77 U/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,U/L,,27.9,CHEMBL612558,,ADMET,,,,Activity,U/L,,,27.9
67193,67193,,,20649553,[],CHEMBL4615370,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring AST level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 157.15 +/- 8.41 U/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,U/L,,177.86,CHEMBL612558,,ADMET,,,,Activity,U/L,,,177.86
67194,67194,,,20649555,[],CHEMBL4615371,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring ALP level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 76.53 +/- 4.31 U/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,U/L,,71.28,CHEMBL612558,,ADMET,,,,Activity,U/L,,,71.28
67195,67195,,,20649557,[],CHEMBL4615372,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring creatinine level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 27.02 +/- 1.22 umol/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,umol/L,,24.36,CHEMBL612558,,ADMET,,,,Activity,umol/L,,,24.36
67196,67196,,,20649559,[],CHEMBL4615373,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring urea formaldehyde level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 8.21 +/- 0.26 mmol/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,mmol/L,,8.08,CHEMBL612558,,ADMET,,,,Activity,mmol/L,,,8.08
67197,67197,,,20649561,[],CHEMBL4615374,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring calcium level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 2.27 +/- 0.059 mmol/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,mmol/L,,2.13,CHEMBL612558,,ADMET,,,,Activity,mmol/L,,,2.13
67198,67198,,,20649563,[],CHEMBL4615375,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring triglyceride level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 0.96 +/- 0.056 mmol/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,mmol/L,,0.77,CHEMBL612558,,ADMET,,,,Activity,mmol/L,,,0.77
67199,67199,,,20649565,[],CHEMBL4615376,"Toxicity in BALB/c mouse xenografted with human KM12C cells assessed as effect on biochemical parameter by measuring total cholesterol level at 100 mg/kg, ig dosed daily for 15 days by automatic chemistry analyzer based analysis (Rvb = 2.32 +/- 0.11 mmol/L)",T,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,0,=,,Activity,mmol/L,,2.35,CHEMBL612558,,ADMET,,,,Activity,mmol/L,,,2.35
67200,67200,,,20649567,[],CHEMBL4615377,"Half life in Sprague-Dawley rat at 100 mg/kg, ig measured after 0.083 to 36 hrs by LC-MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Hour,3475880,=,1,1,=,,T1/2,hr,,28.98,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,28.98
67201,67201,,,20649569,[],CHEMBL4615378,"Tmax in Sprague-Dawley rat at 100 mg/kg, ig measured after 0.083 to 36 hrs by LC-MS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Hour,3475880,=,1,1,=,,Tmax,hr,,2.0,CHEMBL612558,,ADMET,,,,Tmax,hr,UO_0000032,,2.0
67202,67202,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,20649571,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAGASTRIC', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAGASTRIC', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4615379,"Cmax in Sprague-Dawley rat at 100 mg/kg, ig measured after 0.083 to 36 hrs by LC-MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3475880,=,1,1,=,,Cmax,nM,,8.601,CHEMBL612558,,ADMET,,,,Cmax,ng/ml,UO_0000065,,2.893
67203,67203,,,20649573,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAGASTRIC', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAGASTRIC', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'TIME_LOWER', 'standard_units': 'hr', 'standard_value': '0.083', 'text_value': None, 'type': 'TIME_LOWER', 'units': 'hr', 'value': '0.083'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'TIME_UPPER', 'standard_units': 'hr', 'standard_value': '36.0', 'text_value': None, 'type': 'TIME_UPPER', 'units': 'hr', 'value': '36.0'}]",CHEMBL4615380,"AUC (0 to t) in Sprague-Dawley rat at 100 mg/kg, ig measured after 0.083 to 36 hrs by LC-MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3475880,=,1,1,=,,AUC,ng.hr.mL-1,,99.0,CHEMBL612558,,ADMET,,,,AUCt,ng.hr/ml,,,99.0
67204,67204,,,20649575,[],CHEMBL4615381,"MRT (infinity) in Sprague-Dawley rat at 100 mg/kg, ig measured after 0.083 to 36 hrs by LC-MS/MS analysis",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Hour,3475880,=,1,1,=,,MRT,hr,,31.51,CHEMBL612558,,ADMET,,,,MRT,hr,UO_0000032,,31.51
67205,67205,,,20649577,[],CHEMBL4615382,"Bioavailability in Sprague-Dawley rat at 100 mg/kg, ig measured after 0.083 to 36 hrs by LC-MS/MS analysis",A,,,BAO_0003042,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4613270,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3475880,=,1,1,=,,F,%,,0.544,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,0.544
67206,67206,,Not Active,20672659,[],CHEMBL4620912,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as effect on body weight at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS challenge and measured after day 12 to day 18",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67207,67207,,Active,20672662,[],CHEMBL4620915,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in stool consistency scores at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS challenge and measured on day 19",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67208,67208,,Active,20672665,[],CHEMBL4620918,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in stool bleeding scores at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS challenge and measured on day 19",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67209,67209,,Active,20672668,[],CHEMBL4620921,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in disease activity index at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS challenge and measured on day 19",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67210,67210,,Active,20672671,[],CHEMBL4620924,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in DSS-induced colon shortening at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67211,67211,,Not Active,20672674,[],CHEMBL4620927,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in colon swelling at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67212,67212,,Not Active,20672677,[],CHEMBL4620930,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in spleen swelling at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67213,67213,,Active,20672680,[],CHEMBL4620933,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reduction in stool consistency score at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge measured on day 24",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67214,67214,,Active,20672681,[],CHEMBL4620934,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reduction in stool bleeding at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge measured on day 38",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67215,67215,,Active,20672682,[],CHEMBL4620935,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reduction in disease activity index at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge and measured on day 24",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67216,67216,,Active,20672683,[],CHEMBL4620936,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reduction in stool consistency score at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge measured on day 43",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67217,67217,,Active,20672684,[],CHEMBL4620937,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reduction in stool bleeding at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge measured on day 43",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67218,67218,,Active,20672685,[],CHEMBL4620938,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reduction in disease activity index at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge and measured on day 43",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67219,67219,,Active,20672698,[],CHEMBL4620951,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reversal of DSS-induced colon shortening at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67220,67220,,Not Active,20672701,[],CHEMBL4620954,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in DSS-induced colon swelling at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67221,67221,,Active,20672706,[],CHEMBL4620959,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reduction in DSS-induced multiple erosive lesions in colon at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge by hematoxylin and eosin staining based light microscopic analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67222,67222,,Active,20672707,[],CHEMBL4620960,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reduction in DSS-induced loss of colon crypt and columnar epithelium at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge by hematoxylin and eosin staining based light microscopic analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67223,67223,,Active,20672708,[],CHEMBL4620961,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as reduction in DSS-induced inflammatory cell infiltration at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge by hematoxylin and eosin staining based light microscopic analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67224,67224,,Non-Toxic,20672717,[],CHEMBL4620970,"Toxicity in DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as induction of abnormalities in heart at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge by hematoxylin and eosin staining based light microscopic analysis",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
67225,67225,,Non-Toxic,20672718,[],CHEMBL4620971,"Toxicity in DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as induction of abnormalities in liver at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge by hematoxylin and eosin staining based light microscopic analysis",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
67226,67226,,Non-Toxic,20672719,[],CHEMBL4620972,"Toxicity in DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as induction of abnormalities in kidney at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge by hematoxylin and eosin staining based light microscopic analysis",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
67227,67227,,Non-Toxic,20672720,[],CHEMBL4620973,"Toxicity in DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as induction of abnormalities in brain at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge by hematoxylin and eosin staining based light microscopic analysis",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
67228,67228,,Non-Toxic,20672721,[],CHEMBL4620974,"Toxicity in DSS-induced C57BL/6 mouse model of chronic relapsing colitis assessed as induction of abnormalities in lung at 40 mg/kg, po administered once daily for 30 days starting from day 13 post DSS-challenge by hematoxylin and eosin staining based light microscopic analysis",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL612558,,ADMET,,,,Activity,,,,
67229,67229,,Active,20672732,[],CHEMBL4620985,"Antiinflammatory activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in IL17 mRNA level at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge by RT-qPCR analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67230,67230,,Active,20672733,[],CHEMBL4620986,"Antiinflammatory activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in TNFalpha mRNA level at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge by RT-qPCR analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67231,67231,,Active,20672734,[],CHEMBL4620987,"Antiinflammatory activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in IL6 mRNA level at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge by RT-qPCR analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67232,67232,,Not Active,20672735,[],CHEMBL4620988,"Antiinflammatory activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in S1PR1 mRNA level at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge by RT-qPCR analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67233,67233,,Active,20672744,[],CHEMBL4620997,"Anti-colitis activity against DSS-induced C57BL/6 mouse model of subchronic relapsing colitis assessed as reduction in phosphorylated STAT3 level at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge by Western blot analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67234,67234,,Non-Toxic,20672745,[],CHEMBL4620998,"Effect on total STAT3 expression in DSS-induced C57BL/6 mouse model of subchronic relapsing colitis at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge by Western blot analysis",A,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67235,67235,,Non-Toxic,20672746,[],CHEMBL4620999,"Effect on total S1PR1 expression in DSS-induced C57BL/6 mouse model of subchronic relapsing colitis at 40 mg/kg, po administered once daily for 14 days starting from day 5 post DSS-challenge by Western blot analysis",A,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67236,67236,,Active,20672751,[],CHEMBL4621004,Antiinflammatory activity in human THP1 cells assessed as reduction in LPS-induced IL6 mRNA level at 1 uM incubated for 1 hr followed by LPS challenge and measured after 4 to 6 hrs by q-PCR method,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL614245,Homo sapiens,THP-1,9606.0,,,Activity,,,,
67237,67237,,Active,20672752,[],CHEMBL4621005,Antiinflammatory activity in human THP1 cells assessed as reduction in LPS-induced TNFalpha mRNA level at 1 uM incubated for 1 hr followed by LPS challenge and measured after 4 to 6 hrs by q-PCR method,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3481211,,1,0,,,Activity,,,,CHEMBL614245,Homo sapiens,THP-1,9606.0,,,Activity,,,,
67238,67238,,Active,20672755,[],CHEMBL4621008,Inhibition of STAT3 activation in human THP1 cells assessed as reduction in LPS-induced phosphorylated STAT3 expression at 1 uM incubated for 1 hr followed by LPS challenge and measured after 4 to 6 hrs by Western blot analysis,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3481211,,1,0,,,Inhibition,%,,,CHEMBL4026,Homo sapiens,Signal transducer and activator of transcription 3,9606.0,,,INH,,UO_0000187,,
67239,67239,,Active,20672757,[],CHEMBL4621009,Inhibition of STAT3 activation in human THP1 cells assessed as reduction in LPS-induced phosphorylated STAT3 expression at 0.5 uM cotreated with 0.5 uM berberine incubated for 1 hr followed by LPS challenge and measured after 4 to 6 hrs by Western blot analysis,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4619760,J Nat Prod,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3481211,,1,0,,,Inhibition,%,,,CHEMBL4026,Homo sapiens,Signal transducer and activator of transcription 3,9606.0,,,INH,,UO_0000187,,
67240,67240,,,22076131,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4495565,,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3364641,=,52,1,=,,Inhibition,%,,-0.07,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.07
67241,67241,,Active,22416799,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672482,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model assessed as inhibited inflammation in colon at 50 mg/kg administrated for 14 days by H and E staining analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67242,67242,,Active,22416801,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672483,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model assessed as promoted regeneration of intestinal mucosa at 50 mg/kg administrated for 14 days by H and E staining analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67243,67243,,Active,22416804,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672485,Anti-inflammatory activity against DSS-induced ulcerative colitis BALB/c mouse model assessed as reduction in TNF-alpha protein expression in colon tissue at 50 mg/kg administrated for 14 days by Western blot analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67244,67244,,Active,22416807,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672486,Anti-inflammatory activity against DSS-induced ulcerative colitis BALB/c mouse model assessed as reduction in TNF-alpha mRNA expression in colon tissue at 50 mg/kg administrated for 14 days by RT-qPCR analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67245,67245,,Active,22416810,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672487,Anti-inflammatory activity against DSS-induced ulcerative colitis BALB/c mouse model assessed as reduction in IL-6 protein expression in colon tissue at 50 mg/kg administrated for 14 days by Western blot analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67246,67246,,Active,22416813,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672488,Anti-inflammatory activity against DSS-induced ulcerative colitis BALB/c mouse model assessed as reduction in IL-6 mRNA expression in colon tissue at 50 mg/kg administrated for 14 days by RT-qPCR analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67247,67247,,Active,22416816,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672489,Anti-inflammatory activity against DSS-induced ulcerative colitis BALB/c mouse model assessed as reduction in IL-1beta protein expression in colon tissue at 50 mg/kg administrated for 14 days by Western blot analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67248,67248,,Active,22416819,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672490,Anti-inflammatory activity against DSS-induced ulcerative colitis BALB/c mouse model assessed as reduction in IL-1beta mRNA expression in colon tissue at 50 mg/kg administrated for 14 days by RT-qPCR analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67249,67249,,Active,22416821,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672491,Anti-inflammatory activity against DSS-induced ulcerative colitis BALB/c mouse model assessed as reduction in mast cells infiltration in colon tissue at 50 mg/kg administrated for 14 days by aldehyde-fuchsin orange G staining based assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67250,67250,,Active,22416823,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672492,Anti-inflammatory activity against DSS-induced ulcerative colitis BALB/c mouse model assessed as reduction in MPO activity in colon tissue at 50 mg/kg administrated for 14 days by colorimetric method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67251,67251,,Active,22416827,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672494,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model assessed as reduction in colon damage at 50 mg/kg administrated for 14 days by H and E staining analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67252,67252,,Active,22416829,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672495,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model assessed as decrease in histological scores at 50 mg/kg administrated for 14 days by by H and E staining analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67253,67253,,Not Active,22416832,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672496,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model assessed as decrease in spleen weight at 50 mg/kg administrated for 14 days,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67254,67254,,Active,22416835,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672497,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model assessed as increase in cecum weight at 50 mg/kg administrated for 14 days,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67255,67255,,,22416838,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672498,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model assessed as colon length/colon weight ratio at 50 mg/kg administrated for 14 days (Rvb = 22.608 +/- 2.655 cm/g),F,,,BAO_0000193,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,=,1,0,=,,Ratio,,,28.18,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Ratio,,,,28.175
67256,67256,,,22416841,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672499,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model assessed as colon weight at 50 mg/kg administrated for 14 days (Rvb = 0.369 +/- 0.023 g),F,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Gram,3512431,=,1,0,=,,Activity,g,,0.315,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,g,UO_0000021,,0.315
67257,67257,,,22416844,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672500,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model assessed as colon length at 50 mg/kg administrated for 14 days (Rvb = 8.350 +/- 1.111 cm),F,,,BAO_0000181,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Centimeter,3512431,=,1,0,=,,Activity,cm,,8.95,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,cm,UO_0000015,,8.95
67258,67258,,Active,22416847,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '336.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '14.0'}]",CHEMBL4672501,Anti-ulcerative colitis activity in DSS-induced BALB/c mouse ulcerative colitis model of assessed as reduction in disease activity index at 50 mg/kg administrated for 14 days,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67259,67259,,Active,22416850,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4672502,Antibacterial activity against Salmonella paratyphi B 0039 after 24 hrs by microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL2367267,Salmonella enterica subsp. enterica serovar Paratyphi B,Salmonella enterica subsp. enterica serovar Paratyphi B,57045.0,,,Activity,,,,
67260,67260,,Active,22416853,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4672503,Antibacterial activity against Typhoid bacillus 50071-16 after 24 hrs by microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,Activity,,,,
67261,67261,,Active,22416856,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4672504,Antibacterial activity against Escherichia coli 44113-5 after 24 hrs by microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
67262,67262,,Active,22416859,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4672505,Antibacterial activity against Pseudomonas aeruginosa 10211 incubated for 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
67263,67263,,Active,22416862,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4672506,Antibacterial activity against Streptococcus pneumoniae 32215 after 24 hrs by microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
67264,67264,,Active,22416865,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4672507,Antifungal activity against Candida albicans 98001 after 24 hrs by microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,Activity,,,,
67265,67265,,Active,22416868,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4672508,Antibacterial activity against streptococcus hemolyticus 32210 after 24 hrs by microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,,,,
67266,67266,,Active,22416871,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4672509,Antibacterial activity against Staphylococcus aureus 261112-5 after 24 hrs by microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4665879,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3512431,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
67267,67267,,,22430582,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4676237,Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4673249,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3514828,>,1,1,>,,IC50,nM,,50000.0,CHEMBL392,Homo sapiens,A549,9606.0,,,IC50,uM,UO_0000065,,50.0
67268,67268,,,22430599,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4676238,Antiproliferative activity against human A2780 cells assessed as reduction in cell viability after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4673249,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3514828,>,1,1,>,,IC50,nM,,50000.0,CHEMBL614004,Homo sapiens,A2780,9606.0,,,IC50,uM,UO_0000065,,50.0
67269,67269,,,22430616,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4676239,Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4673249,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3514828,>,1,1,>,,IC50,nM,,50000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,uM,UO_0000065,,50.0
67270,67270,,,22430635,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4676240,Antiproliferative activity against human HT29 cells assessed as reduction in cell viability after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4673249,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3514828,>,1,1,>,,IC50,nM,,50000.0,CHEMBL384,Homo sapiens,HT-29,9606.0,,,IC50,uM,UO_0000065,,50.0
67271,67271,,,22430654,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4676241,Antiproliferative activity against human PANC1 cells assessed as reduction in cell viability after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4673249,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3514828,>,1,1,>,,IC50,nM,,50000.0,CHEMBL614139,Homo sapiens,PANC-1,9606.0,,,IC50,uM,UO_0000065,,50.0
67272,67272,,,22430685,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4676242,Antiproliferative activity against human PC-3 cells assessed as reduction in cell viability after 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4673249,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.5,0,http://www.openphacts.org/units/Nanomolar,3514828,=,1,1,=,,IC50,nM,,31720.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,IC50,uM,UO_0000065,,31.72
67273,67273,,,22430702,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4676243,Antiproliferative activity against human L02 cells assessed as reduction in cell viability after 48 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4673249,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3514828,>,1,1,>,,IC50,nM,,50000.0,CHEMBL4296457,Homo sapiens,L02,9606.0,,,IC50,uM,UO_0000065,,50.0
67274,67274,,,22430750,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microM', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microM', 'standard_value': '80.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microM', 'value': '80.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4676290,Synergistic antiproliferative activity against human HepG2 cells assessed as combination index at 20 to 80 uM after 48 hrs in presence of 10 to 40 uM HN by MTT assay,F,,,BAO_0000179,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4673249,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3514828,>,1,0,>,,CI,,,1.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,CI,,,,1.0
67275,67275,,Not Active,22430757,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '40.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '40.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4676295,Induction of morphological changes in human HepG2 cells assessed as accumulation of cytoplasmic vacuoles at 40 uM after 24 hrs by optical microscopic method,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4673249,J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3514828,,1,0,,,Activity,,,,CHEMBL395,Homo sapiens,HepG2,9606.0,,,Activity,,,,
67276,67276,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22787275,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5833', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '35.0'}]",CHEMBL4708695,Inhibition of recombinant human Prolyl oligopeptidase expressed in Escherichia coli expression system using (Z)-Gly-Pro-p-nitroanilide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured for 30 mins by spectrophotometric analysis,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4706517,Eur J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3538260,=,1,1,=,,IC50,nM,,142000.0,CHEMBL3202,Homo sapiens,Prolyl endopeptidase,9606.0,,,IC50,uM,UO_0000065,,142.0
67277,67277,,,22787298,[],CHEMBL4708696,"Selectivity index, ratio of IC50 for human butyrylcholinesterase in plasma using butyrylthiocholine iodide as substrate to IC50 for recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate by Ellman's method",B,,,BAO_0000179,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4706517,Eur J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3538260,=,1,0,=,,Ratio IC50,,,2.7,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,2.7
67278,67278,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22787321,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.08333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '5.0'}]",CHEMBL4708697,Inhibition of recombinant human acetylcholinesterase using acetylthiocholine iodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4706517,Eur J Med Chem,2020.0,"{'bei': '14.15', 'le': '0.26', 'lle': '1.66', 'sei': '11.67'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.76,0,http://www.openphacts.org/units/Nanomolar,3538260,=,1,1,=,,IC50,nM,,17400.0,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,uM,UO_0000065,,17.4
67279,67279,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22787344,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.08333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '5.0'}]",CHEMBL4708698,Inhibition of human butyrylcholinesterase in plasma using butyrylthiocholineiodide as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured at 2 mins interval by Ellman's method,B,,,BAO_0000190,BAO_0000366,cell-free format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4706517,Eur J Med Chem,2020.0,"{'bei': '12.86', 'le': '0.24', 'lle': '1.23', 'sei': '10.60'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.33,0,http://www.openphacts.org/units/Nanomolar,3538260,=,1,1,=,,IC50,nM,,47200.0,CHEMBL1914,Homo sapiens,Butyrylcholinesterase,9606.0,,,IC50,uM,UO_0000065,,47.2
67280,67280,,,22787370,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4708702,Cytotoxicity against CHO-K1 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4706517,Eur J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3538260,=,1,1,=,,IC50,nM,,336000.0,CHEMBL614031,Cricetulus griseus,CHO-K1,10029.0,,,IC50,uM,UO_0000065,,336.0
67281,67281,,,22787393,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL4708703,Antioxidant activity assessed as radical scavenging activity measured after 30 mins by microplate reader based DPPH assay,F,,,BAO_0000188,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4706517,Eur J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3538260,=,1,1,=,,EC50,nM,,5500000.0,CHEMBL2362975,,No relevant target,,,,EC50,uM,UO_0000065,,5500.0
67282,67282,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22787418,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4708704,Inhibition of HFIP-pretreated amyloid beta(1 to 42) (unknown origin) self-aggregation at 50 uM measured at interval of 10 mins for 72 hrs by thioflavin-T fluorescence method,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4706517,Eur J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3538260,=,1,1,=,,Inhibition,%,,70.5,CHEMBL2487,Homo sapiens,Amyloid-beta A4 protein,9606.0,,,INH,%,UO_0000187,,70.5
67283,67283,,,22787423,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '25.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '25.0'}]",CHEMBL4708705,Inhibition of HFIP-pretreated Tau (306 to 336) (unknown origin) self-aggregation at 25 uM measured at interval of 10 mins for overnight with 1 min shaking by thioflavin-T fluorescence method,B,,,BAO_0000201,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4706517,Eur J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3538260,=,1,1,=,,Inhibition,%,,25.0,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,25.0
67284,67284,,,22787428,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '6.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '6.0'}]",CHEMBL4708706,Permeability of the compound at pH 7.4 measured after 6 hrs by PAMPA method,A,,,BAO_0002808,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4706517,Eur J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3538260,=,1,0,=,,permeability,10^-6 cm/s,,0.2,CHEMBL612558,,ADMET,,,,permeability,10^-6 cm/s,,,0.2
67285,67285,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22787444,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.25', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '75.0'}]",CHEMBL4708707,Inhibition of recombinant human His-tagged Prolyl oligopeptidase expressed in Escherichia coli expression system preincubated with enzyme for 15 mins followed by addition of ZGP-AMC substrate measured after 1 hr by fluorescence assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4706517,Eur J Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,1,http://www.openphacts.org/units/Nanomolar,3538260,=,1,1,=,,IC50,nM,,145000.0,CHEMBL3202,Homo sapiens,Prolyl endopeptidase,9606.0,,,IC50,uM,UO_0000065,,145.0
67286,67286,,,22845968,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '1.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '25.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '25.0'}]",CHEMBL4721991,Anti-neuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced TNF-alpha production by measuring TNF-alpha level at 1 uM preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA (Rvb = 100 +/- 0%),F,,,BAO_0001103,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4715828,Bioorg Med Chem,2018.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3547140,=,1,0,=,,Activity,%,,25.0,CHEMBL614781,Mus musculus,BV-2,10090.0,,,Activity,%,UO_0000187,,25.0
67287,67287,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22891969,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '25.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '25.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.3333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '20.0'}]",CHEMBL4729678,Inhibition of recombinant human SARM1 TIR domain (561 to 724 residues) expressed in Escherichia coli C43 (DE3) cells lysates using ENAD as substrate at 25 uM preincubated for 20 mins followed by ENAD addition and measured after 1 hr relative to control,B,,,BAO_0000201,BAO_0000220,subcellular format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4725376,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3552876,=,1,1,=,,Inhibition,%,,70.0,CHEMBL4523350,Homo sapiens,NAD(+) hydrolase SARM1,9606.0,,,INH,%,UO_0000187,,70.0
67288,67288,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22891973,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.3333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '20.0'}]",CHEMBL4729679,Inhibition of recombinant human SARM1 TIR domain (561 to 724 residues) expressed in Escherichia coli C43 (DE3) cells lysates using ENAD as substrate preincubated for 20 mins followed by ENAD addition and measured at 15 sec interval for 15 mins,B,,,BAO_0000190,BAO_0000220,subcellular format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4725376,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3552876,=,1,1,=,,IC50,nM,,140000.0,CHEMBL4523350,Homo sapiens,NAD(+) hydrolase SARM1,9606.0,,,IC50,uM,UO_0000065,,140.0
67289,67289,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22891977,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.3333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '20.0'}]",CHEMBL4729680,Noncompetitive inhibition of recombinant human SARM1 TIR domain (561 to 724 residues) expressed in Escherichia coli C43 (DE3) cells lysates assessed as EADPR formation using ENAD as substrate preincubated for 20 mins followed by ENAD addition and measured at 15 sec interval for 1 hr,B,,,BAO_0000192,BAO_0000220,subcellular format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4725376,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3552876,=,1,1,=,,Ki,nM,,130000.0,CHEMBL4523350,Homo sapiens,NAD(+) hydrolase SARM1,9606.0,,,Ki,uM,UO_0000065,,130.0
67290,67290,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22891981,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.3333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '20.0'}]",CHEMBL4729682,Inhibition of recombinant human SARM1 SAM1-2-TIR domains (412 to 724 residues) expressed in Escherichia coli C43 (DE3) cells lysates using ENAD as substrate preincubated for 20 mins followed by ENAD addition and measured at 15 sec interval for 1 hr,B,,,BAO_0000190,BAO_0000220,subcellular format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4725376,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3552876,=,1,1,=,,IC50,nM,,110000.0,CHEMBL4523350,Homo sapiens,NAD(+) hydrolase SARM1,9606.0,,,IC50,uM,UO_0000065,,110.0
67291,67291,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22891982,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.3333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '20.0'}]",CHEMBL4729683,Inhibition of recombinant human SARM1 SAM1-2-TIR domains (412 to 724 residues) expressed in Expi293 cells lysates using ENAD as substrate preincubated for 20 mins followed by ENAD addition and measured at 15 sec interval for 1 hr,B,,,BAO_0000190,BAO_0000220,subcellular format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4725376,Bioorg Med Chem,2020.0,"{'bei': '12.23', 'le': '0.22', 'lle': '1.01', 'sei': '10.08'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.11,0,http://www.openphacts.org/units/Nanomolar,3552876,=,1,1,=,,IC50,nM,,77000.0,CHEMBL4523350,Homo sapiens,NAD(+) hydrolase SARM1,9606.0,,,IC50,uM,UO_0000065,,77.0
67292,67292,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22891983,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.3333', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '20.0'}]",CHEMBL4729684,Inhibition of purified human SARM1 TIR domain (561 to 724 residues) using ENAD as substrate preincubated for 20 mins followed by ENAD addition and measured at 15 sec interval for 1 hr,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4725376,Bioorg Med Chem,2020.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3552876,=,1,1,=,,IC50,nM,,140000.0,CHEMBL4523350,Homo sapiens,NAD(+) hydrolase SARM1,9606.0,,,IC50,uM,UO_0000065,,140.0
67293,67293,,,22930396,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4738576,Inhibition of amyloid beta (1 to 42 ) (unknown origin) aggregation at 10 uM after 20 hrs by thioflavin-T fluorescence method relative to control,B,,,BAO_0000201,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4732228,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3560555,=,1,1,=,,Inhibition,%,,32.0,CHEMBL2487,Homo sapiens,Amyloid-beta A4 protein,9606.0,,,INH,%,UO_0000187,,32.0
67294,67294,,,22930410,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'mg', 'value': '1.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL4738577,Water solubility of the compound at 1 mg incubated for 12 hrs under shaking condition by UV-HPLC analysis,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4732228,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3560555,=,1,1,=,,Solubility,nM,,1784000.0,CHEMBL2362975,,No relevant target,,,,solubility,uM,UO_0000065,,1784.0
67295,67295,,,22930420,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL4738578,Ratio of compound solubility to curcumin solubility in water after 12 hrs by UV-HPLC analysis,P,,,BAO_0000193,BAO_0000100,small-molecule physicochemical format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4732228,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3560555,=,1,0,=,,Ratio,,,9000.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,9000.0
67296,67296,,,22930424,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4738579,Cytotoxicity against rat PC12 cells assessed as reduction in cell viability incubated for 24 hrs by WST-8 assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4732228,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3560555,>,1,1,>,,CC50,nM,,150000.0,CHEMBL612556,Rattus norvegicus,PC-12,10116.0,,,CC50,uM,UO_0000065,,150.0
67297,67297,,,22994937,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '1.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '1.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775904,Inhibition of LPS + nigericin-induced IL-1beta secretion in PMA-differentiated human THP-1 cells incubated for 1 to 24 hrs by Immunoblot analysis,F,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.29,0,http://www.openphacts.org/units/Nanomolar,3571520,=,1,1,=,,IC50,nM,,5100.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,5.1
67298,67298,,Active,22994938,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.5'}]",CHEMBL4775905,Inhibition of LPS + nigericin-induced IL-1beta secretion in mouse BMDM cells incubated with LPS followed by compound treatment for 2 hrs and stimulated with nigericin for 0.5 hrs by Immunoblot analysis,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67299,67299,,Non-Toxic,22994939,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': '<=40', 'standard_type': 'Dose', 'standard_units': None, 'standard_value': None, 'text_value': '<=40', 'type': 'Dose', 'units': 'microM', 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775906,Toxicity in mouse BMDM cells assessed as induction of cell death up to 40 uM incubated for 24 hrs by MTS assay,T,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67300,67300,,Non-Toxic,22994940,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775907,Toxicity in mouse BMDM cells assessed as induction of apoptosis by measuring cleaved caspase-3 levels up to 40 uM incubated for 24 hrs by immunoblot analysis,T,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67301,67301,,Non-Toxic,22994941,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775908,Toxicity in mouse BMDM cells assessed as induction of apoptosis by measuring cleaved caspase-7 levels up to 40 uM incubated for 24 hrs by immunoblot analysis,T,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67302,67302,,Non-Toxic,22994942,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': '<=40', 'standard_type': 'Dose', 'standard_units': None, 'standard_value': None, 'text_value': '<=40', 'type': 'Dose', 'units': 'microM', 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775909,Toxicity in mouse BMDM cells assessed as induction of apoptosis by measuring cleaved caspase-9 levels up to 40 uM incubated for 24 hrs by immunoblot analysis,T,,,BAO_0000375,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67303,67303,,,22994960,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775910,Inhibition of LPS + nigericin-induced IL-1beta secretion in PMA-differentiated human THP-1 cells at 20 uM incubated for 24 hrs by ELISA,F,,,BAO_0000201,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,=,1,1,=,,Inhibition,%,,72.0,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,72.0
67304,67304,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Active,22994974,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '100.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '8.0'}]",CHEMBL4775918,Binding affinity to NEK7 in PMA-differentiated human THP-1 cells assessed as reduction in Cy3-labeled target proteins at 100 uM incubated for 8 hrs using probe-16 by fluorescent gel imaging analysis,B,,,BAO_0000375,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL4849,Homo sapiens,Serine/threonine-protein kinase NEK7,9606.0,,,Activity,,,,
67305,67305,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Active,22994975,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '100.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '8.0'}]",CHEMBL4775919,Binding affinity to NEK7 in PMA-differentiated human THP-1 cells at 100 uM incubated for 8 hrs by streptavidin-bead enrichment and immunoblot assay,B,,,BAO_0000375,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL4849,Homo sapiens,Serine/threonine-protein kinase NEK7,9606.0,,,Activity,,,,
67306,67306,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22994979,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.9167', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '55.0'}]",CHEMBL4775923,Inhibition of purified recombinant human NEK7 incubated for 15 mins before ATP and substrate addition and further incubated for 40 mins by ADPGlo kinase assay,B,,,BAO_0000190,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,"{'bei': '15.98', 'le': '0.29', 'lle': '2.28', 'sei': '13.18'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,5.38,0,http://www.openphacts.org/units/Nanomolar,3571520,=,1,1,=,,IC50,nM,,4200.0,CHEMBL4849,Homo sapiens,Serine/threonine-protein kinase NEK7,9606.0,,,IC50,uM,UO_0000065,,4.2
67307,67307,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22994980,[],CHEMBL4775924,Binding affinity to purified recombinant human NEK7 by SPR analysis,B,,,BAO_0000034,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,"{'bei': '14.29', 'le': '0.26', 'lle': '1.71', 'sei': '11.78'}",CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.81,0,http://www.openphacts.org/units/Nanomolar,3571520,=,1,1,=,,Kd,nM,,15600.0,CHEMBL4849,Homo sapiens,Serine/threonine-protein kinase NEK7,9606.0,,,Kd,uM,UO_0000065,,15.6
67308,67308,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Dose-dependent effect,22994981,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775925,Inhibition of NEK7-NLRP3 interaction (unknown origin) expressed in HEK293 cells incubated for 24 hrs by Co-IP assay,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67309,67309,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Dose-dependent effect,22994982,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775926,Inhibition of NEK7-NLRP3 interaction in human THP-1 cells incubated for 24 hrs by Co-IP assay,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67310,67310,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Active,22994983,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775927,Inhibition of NEK7-NLRP3 interaction (unknown origin) expressed in HEK293 cells at 10 uM incubated for 24 hrs by Co-IP assay,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67311,67311,,Not Active,22994985,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4775928,Inhibition of NEK7 R121A mutant-NLRP3 interaction (unknown origin) expressed in HEK293 cells at 10 uM incubated for 24 hrs by Co-IP assay,B,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67312,67312,,Active,22994986,[],CHEMBL4775929,Inhibition of LPS + nigericin-induced IL-1beta secretion in human THP-1 cells pre-treatment for 4 hrs before LPS + nigericin by immunoblot analysis,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67313,67313,,Active,22994987,[],CHEMBL4775930,Inhibition of LPS + nigericin-induced caspase-1 activation in human THP-1 cells pre-treatment for 4 hrs before LPS + nigericin by immunoblot analysis,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67314,67314,,Not Active,22994988,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microM', 'standard_value': '2.5', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microM', 'value': '2.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microM', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4775931,Inhibition of LPS + nigericin-induced NLRP3 expression in human THP-1 cells at 2.5 to 20 uM pre-treatment for 4 hrs before LPS + nigericin by immunoblot analysis,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67315,67315,,Not Active,22994989,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microM', 'standard_value': '2.5', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microM', 'value': '2.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microM', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4775932,Inhibition of LPS + nigericin-induced pro-IL-beta expression in human THP-1 cells at 2.5 to 20 uM pre-treatment for 4 hrs before LPS + nigericin by immunoblot analysis,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67316,67316,,Active,22994990,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microM', 'standard_value': '2.5', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microM', 'value': '2.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microM', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4775933,Inhibition of LPS + nigericin-induced IL-1beta secretion in mouse BMDM at 2.5 to 20 uM pre-treatment for 4 hrs before LPS + nigericin by immunoblot analysis,F,,,BAO_0000201,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67317,67317,,Active,22994991,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microM', 'standard_value': '2.5', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microM', 'value': '2.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microM', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4775934,Inhibition of LPS + nigericin-induced caspase-1 activation in mouse BMDM at 2.5 to 20 uM pre-treatment for 4 hrs before LPS + nigericin by immunoblot analysis,F,,,BAO_0000201,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67318,67318,,Not Active,22994992,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microM', 'standard_value': '2.5', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microM', 'value': '2.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microM', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4775935,Inhibition of LPS + nigericin-induced NLRP3 expression in mouse BMDM at 2.5 to 20 uM pre-treatment for 4 hrs before LPS + nigericin by immunoblot analysis,F,,,BAO_0000201,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67319,67319,,Not Active,22994993,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microM', 'standard_value': '2.5', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microM', 'value': '2.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microM', 'value': '20.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4775936,Inhibition of LPS + nigericin-induced pro-IL-1beta expression in mouse BMDM at 2.5 to 20 uM pre-treatment for 4 hrs before LPS + nigericin by immunoblot analysis,F,,,BAO_0000201,BAO_0000221,tissue-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67320,67320,,Active,22994994,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microM', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microM', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4775937,Inhibition of LPS + nigericin-induced ASC-pyroptosome formation in human THP-1 cells at 5 to 10 uM uM pre-treatment for 4 hrs before LPS + nigericin addition by immunofluorescence analysis,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67321,67321,,Not Active,22994995,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL4775938,Inhibition of AIM2-induced IL-1beta activation in human THP-1 cells at 10 uM pre-treatment for 2 hrs before AIM2 addition,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67322,67322,,Not Active,22994996,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL4775939,Inhibition of Salmonella-induced NLRC4 inflammasome activation in human THP-1 cells at 10 uM pre-treatment for 2 hrs before Salmonella addition,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://qudt.org/vocab/unit#Percent,3571520,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
67323,67323,,Not Active,22994997,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL4775940,"Inhibition of serum IL-1beta production in NEK7 knockdown C57BL/6 mouse model at 5 mg/kg, ip dosed three times every 12 hrs followed by LPS challenge by ELISA",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67324,67324,,Active,22994998,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL4775941,"Inhibition of serum IL-1beta production in NEK7 wild type C57BL/6 mouse model at 5 mg/kg, ip dosed three times every 12 hrs followed by LPS challenge by ELISA",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
67325,67325,,Active,22994999,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL4775942,"Antiinflammatory activity in NEK7 wild type C57BL/6 mouse model assessed as reduction in inflammatory infiltration in liver at 5 mg/kg, ip dosed three times every 12 hrs followed by LPS challenge by H and E staining",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67326,67326,,Active,22995000,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL4775943,"Antiinflammatory activity in NEK7 wild type C57BL/6 mouse model assessed as reduction in lesion in heart in at 5 mg/kg, ip dosed three times every 12 hrs followed by LPS challenge by H and E staining",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67327,67327,,Active,22995001,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL4775944,"Antiinflammatory activity in NEK7 wild type C57BL/6 mouse model assessed as reduction in lesion in lung in at 5 mg/kg, ip dosed three times every 12 hrs followed by LPS challenge by H and E staining",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67328,67328,,Active,22995002,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL4775945,"Antiinflammatory activity in NEK7 wild type C57BL/6 mouse model assessed as reduction in lesion in kidney in at 5 mg/kg, ip dosed three times every 12 hrs followed by LPS challenge by H and E staining",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67329,67329,,Active,22995003,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/kg', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '12.0'}]",CHEMBL4775946,"Antiinflammatory activity in NEK7 wild type C57BL/6 mouse model assessed as reduction in lesion in spleen in at 5 mg/kg, ip dosed three times every 12 hrs followed by LPS challenge by H and E staining",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4765493,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,3571520,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
67330,67330,,,23200448,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4820718,Down regulation of PCSK9 mRNA expression in human HepG2 cells incubated for 24 hrs by SYBR green dye-based qRT-PCR analysis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4819031,J Nat Prod,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.86,0,http://www.openphacts.org/units/Nanomolar,3608062,=,1,1,=,,IC50,nM,,13800.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,13.8
67331,67331,,,23285345,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838230,Antibacterial activity against penicillin-susceptible Bacillus subtilis ATCC 9372 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,64.0
67332,67332,,,23285412,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838231,Antibacterial activity against penicillin-susceptible Bacillus pumilus CMCC 63202 assessed as bacterial growth inhibition by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,,MIC,ug ml-1,UO_0000274,,64.0
67333,67333,,,23285479,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838232,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
67334,67334,,,23285546,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838233,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolate 1 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,64.0
67335,67335,,,23285613,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838234,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,64.0
67336,67336,,,23285680,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838235,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis ATCC19434 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,64.0
67337,67337,,,23285747,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838236,Antibacterial activity against penicillin-susceptible Pseudomonas aeruginosa ATCC27853 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
67338,67338,,,23285814,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838237,Antibacterial activity against penicillin-susceptible Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
67339,67339,,,23285881,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838238,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
67340,67340,,,23285948,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838239,Antibacterial activity against penicillin-resistant Staphylococcus aureus assessed as inhibition of bacterial growth measured by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
67341,67341,,,23286015,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838240,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth measured by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
67342,67342,,,23286082,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838241,Antibacterial activity against penicillin-resistant Staphylococcus epidermidis assessed as inhibition of bacterial growth measured by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,64.0
67343,67343,,,23286149,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838242,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 2 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,64.0
67344,67344,,,23286216,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838243,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,64.0
67345,67345,,,23286283,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4838244,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51559 assessed as bacterial growth inhibition incubated for 24 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL4837210,Eur J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3623278,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,64.0
67346,67346,,,24663243,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5097558,Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5096175,Bioorg Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,3842900,=,1,1,=,,IC50,nM,,25000.0,CHEMBL394,Homo sapiens,HCT-116,9606.0,,,IC50,uM,UO_0000065,,25.0
67347,67347,,,24663245,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5097559,Antiproliferative activity against human LS174T cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5096175,Bioorg Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,3842900,=,1,1,=,,IC50,nM,,25000.0,CHEMBL614097,Homo sapiens,LS174T,9606.0,,,IC50,uM,UO_0000065,,25.0
67348,67348,,,24663247,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5097560,Antiproliferative activity against human SW620 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5096175,Bioorg Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,3842900,=,1,1,=,,IC50,nM,,25000.0,CHEMBL612262,Homo sapiens,SW-620,9606.0,,,IC50,uM,UO_0000065,,25.0
67349,67349,,,24663249,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5097561,Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5096175,Bioorg Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,3842900,=,1,1,=,,IC50,nM,,25000.0,CHEMBL614909,Homo sapiens,SGC-7901,9606.0,,,IC50,uM,UO_0000065,,25.0
67350,67350,,,24663251,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5097562,Antiproliferative activity against human Eca-109 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5096175,Bioorg Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,3842900,=,1,1,=,,IC50,nM,,25000.0,CHEMBL614668,Homo sapiens,ECa-109 cell line,9606.0,,,IC50,uM,UO_0000065,,25.0
67351,67351,,,24663253,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5097563,Antiproliferative activity against human MKN-28 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5096175,Bioorg Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,3842900,=,1,1,=,,IC50,nM,,25000.0,CHEMBL614353,Homo sapiens,MKN-28,9606.0,,,IC50,uM,UO_0000065,,25.0
67352,67352,,,24663255,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5097564,Antiproliferative activity against human HCT-8 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5096175,Bioorg Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,3842900,=,1,1,=,,IC50,nM,,25000.0,CHEMBL613510,Homo sapiens,HCT-8,9606.0,,,IC50,uM,UO_0000065,,25.0
67353,67353,,,24663257,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5097565,Antiproliferative activity against mouse CCRF S-180 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5096175,Bioorg Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,4.6,0,http://www.openphacts.org/units/Nanomolar,3842900,=,1,1,=,,IC50,nM,,25000.0,CHEMBL614027,Mus musculus,CCRF S-180,10090.0,,,IC50,uM,UO_0000065,,25.0
67354,67354,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24987738,[],CHEMBL5228672,Inhibition of recombinant Staphylococcus aureus SrtA using DabcylQALPETGEE-Edans as substrate by FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5226340,J Med Chem,2021.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,3906968,=,1,1,=,,IC50,ug.mL-1,,8.7,CHEMBL5362,Staphylococcus aureus,Sortase A,1280.0,,,IC50,ug ml-1,UO_0000274,,8.7
67355,67355,,,25103763,[],CHEMBL5262775,Antimycobacterial activity against Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936558,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,25.0
67356,67356,,,25103857,[],CHEMBL5262811,Antimycobacterial activity against Mycobacterium smegmatis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936558,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.78
67357,67357,,,25103963,[],CHEMBL5262826,Antimycobacterial activity against Mycobacterium intracellulare,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936558,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,0.78
67358,67358,,Inactive,25402426,[],CHEMBL5303715,Cytotoxicity activity against human HepG2 cells assessed by CellTiter-Glo luminescent cell viability assay.,T,,,BAO_0000198,BAO_0000219,cell-based format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL5303711,,2023.0,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,http://www.openphacts.org/units/Nanomolar,3944811,=,68,0,=,,IC50 relative,nM,,14400.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50 relative,nM,UO_0000065,,14400.0
67359,67359,,,2323258,[],CHEMBL1006881,Antibiotic activity against Staphylococcus aureus at 200 ug/disk after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CO[C@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,,,CHEMBL1151253,J Nat Prod,2004.0,,CHEMBL463558,MEMBRANOLIDE D,CHEMBL463558,,0,http://qudt.org/vocab/unit#Millimeter,789101,=,1,1,=,,IZ,mm,,7.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,7.0
67360,67360,,,2323259,[],CHEMBL1006880,Antibiotic activity against Escherichia coli at 200 ug/disk after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CO[C@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,,,CHEMBL1151253,J Nat Prod,2004.0,,CHEMBL463558,MEMBRANOLIDE D,CHEMBL463558,,0,http://qudt.org/vocab/unit#Millimeter,789101,=,1,1,=,,IZ,mm,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,6.0
67361,67361,,,2323260,[],CHEMBL1006879,Antifungal activity against Candida albicans at 200 ug/disk after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CO[C@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,,,CHEMBL1151253,J Nat Prod,2004.0,,CHEMBL463558,MEMBRANOLIDE D,CHEMBL463558,,0,http://qudt.org/vocab/unit#Millimeter,789101,=,1,1,=,,IZ,mm,,9.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,IZ,mm,UO_0000016,,9.0
67362,67362,,,20659947,[],CHEMBL4618069,Cytotoxicity against mouse J774A.1 cells incubated for 72 hrs by CellTiter 96 AQueous One solution cell proliferation assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CO[C@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,,,CHEMBL4616650,J Nat Prod,2020.0,,CHEMBL463558,MEMBRANOLIDE D,CHEMBL463558,4.02,0,http://www.openphacts.org/units/Nanomolar,3478491,=,1,1,=,,IC50,nM,,95000.0,CHEMBL614040,Mus musculus,J774.A1,10090.0,,,IC50,uM,UO_0000065,,95.0
67363,67363,,,20659959,[],CHEMBL4618068,Antileishmanial activity against Leishmania donovani MHOM/SD/75/1246/130 amastigotes infected in mouse J774A.1 cells incubated for 72 hrs by DRAQ5 fluorescent probe based assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CO[C@H]1O[C@@H](OC)c2c1ccc([C@@]1(C)CCCC(C)(C)C1)c2[C@@H](C)C(=O)O,,,CHEMBL4616650,J Nat Prod,2020.0,,CHEMBL463558,MEMBRANOLIDE D,CHEMBL463558,5.18,0,http://www.openphacts.org/units/Nanomolar,3478491,=,1,1,=,,IC50,nM,,6600.0,CHEMBL367,Leishmania donovani,Leishmania donovani,5661.0,,,IC50,uM,UO_0000065,,6.6
67364,67364,,Active,2547284,[],CHEMBL979406,Antibiotic activity against Staphylococcus aureus at 50 ug/disk,F,,,BAO_0000375,BAO_0000218,organism-based format,N/C(=C\c1cc(O)c(O)c(O)c1)C(=O)N[C@@H](Cc1c[nH]c2cc(Br)ccc12)C(=O)N/C=C/c1ccc(O)c(O)c1,,,CHEMBL1158661,J Nat Prod,1998.0,,CHEMBL516411,CELENAMIDE E,CHEMBL516411,,0,,737016,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
67365,67365,,Active,2547285,[],CHEMBL979407,Antibiotic activity against Micrococcus luteus at 50 ug/disk,F,,,BAO_0000375,BAO_0000218,organism-based format,N/C(=C\c1cc(O)c(O)c(O)c1)C(=O)N[C@@H](Cc1c[nH]c2cc(Br)ccc12)C(=O)N/C=C/c1ccc(O)c(O)c1,,,CHEMBL1158661,J Nat Prod,1998.0,,CHEMBL516411,CELENAMIDE E,CHEMBL516411,,0,,737016,,1,0,,,Activity,,,,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,Activity,,,,
67366,67366,,Active,2547286,[],CHEMBL979408,Antibiotic activity against Bacillus subtilis at 50 ug/disk,F,,,BAO_0000375,BAO_0000218,organism-based format,N/C(=C\c1cc(O)c(O)c(O)c1)C(=O)N[C@@H](Cc1c[nH]c2cc(Br)ccc12)C(=O)N/C=C/c1ccc(O)c(O)c1,,,CHEMBL1158661,J Nat Prod,1998.0,,CHEMBL516411,CELENAMIDE E,CHEMBL516411,,0,,737016,,1,0,,,Activity,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Activity,,,,
67367,67367,,Active,2547287,[],CHEMBL979409,Antibiotic activity against Enterococcus faecalis at 50 ug/disk,F,,,BAO_0000375,BAO_0000218,organism-based format,N/C(=C\c1cc(O)c(O)c(O)c1)C(=O)N[C@@H](Cc1c[nH]c2cc(Br)ccc12)C(=O)N/C=C/c1ccc(O)c(O)c1,,,CHEMBL1158661,J Nat Prod,1998.0,,CHEMBL516411,CELENAMIDE E,CHEMBL516411,,0,,737016,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
67368,67368,,,2502935,[],CHEMBL986830,Bactericidal activity against methicillin-resistant Staphylococcus aureus SA2 by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780131,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
67369,67369,,,2502936,[],CHEMBL986830,Bactericidal activity against methicillin-resistant Staphylococcus aureus SA2 by microdilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,=,1,0,=,,MBC,mg/L,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/L,,,1.0
67370,67370,,,2502937,[],CHEMBL986831,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus by microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780131,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,2.0
67371,67371,,,2502938,[],CHEMBL986831,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus by microdilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,=,1,0,=,,MBC,mg/L,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/L,,,2.0
67372,67372,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2502950,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '58.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '58.0'}]",CHEMBL986838,Cmax in rabbit plasma at 58 mg/kg after 12 hrs,A,,,BAO_0002119,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/Nanomolar,780131,=,1,1,=,,Cmax,nM,,31984.81,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmax,mg/L,UO_0000065,,21.9
67373,67373,,,2502951,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '58.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '58.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '12.0'}]",CHEMBL986839,AUC in rabbit plasma at 58 mg/kg after 12 hrs,A,,,BAO_0002120,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,=,1,1,=,,AUC,ng.hr.mL-1,,71200.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,mg.hr/L,,,71.2
67374,67374,,,2502952,[],CHEMBL986840,Half life in rabbit plasma at 58 mg/kg after 12 hrs,A,,,BAO_0002115,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,780131,=,1,1,=,,T1/2,hr,,2.4,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,t1/2,hr,UO_0000032,,2.4
67375,67375,,Active,2502957,[],CHEMBL986846,Bactericidal activity against methicillin-resistant Staphylococcus aureus SA2 in rabbit endocarditis model at 4 times MIC after 48 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
67376,67376,,Active,2502958,[],CHEMBL986847,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus in rabbit endocarditis model at 4 times MIC after 48 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
67377,67377,,,2502959,[],CHEMBL986842,Bactericidal activity against methicillin-resistant Staphylococcus aureus SA2 in rabbit endocarditis model assessed per gram of aortic vegetation at 58 mg/kg infused every 12 hrs for 4 days measured after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,=,1,0,=,,log10cfu,,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,2.5
67378,67378,,,2502960,[],CHEMBL986843,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus in rabbit endocarditis model assessed per gram of aortic vegetation at 58 mg/kg infused every 12 hrs for 4 days measured after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,=,1,0,=,,log10cfu,,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,3.0
67379,67379,,,2502961,[],CHEMBL986844,Bactericidal activity against methicillin-resistant Staphylococcus aureus SA2 in rabbit endocarditis model assessed as growth inhibition at 58 mg/kg infused every 12 hrs for 4 days measured after 48 hrs,F,,,BAO_0000096,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,780131,=,1,0,=,,GI,%,,90.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,GI,%,UO_0000187,,90.0
67380,67380,,,2502962,[],CHEMBL986845,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus in rabbit endocarditis model assessed as growth inhibition at 58 mg/kg infused every 12 hrs for 4 days measured after 48 hrs,F,,,BAO_0000096,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,780131,=,1,0,=,,GI,%,,60.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,GI,%,UO_0000187,,60.0
67381,67381,,Active,2502971,[],CHEMBL986829,Antibacterial activity against Citrobacter freundii,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,,1,0,,,Activity,,,,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Activity,,,,
67382,67382,,Active,2502972,[],CHEMBL986854,Antibacterial activity against Escherichia coli,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
67383,67383,,Active,2502973,[],CHEMBL986855,Antibacterial activity against Klebsiella pneumoniae,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,,1,0,,,Activity,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,
67384,67384,,Active,2502974,[],CHEMBL986856,Antibacterial activity against Morganella morganii,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,,1,0,,,Activity,,,,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,Activity,,,,
67385,67385,,Active,2502975,[],CHEMBL986857,Antibacterial activity against Haemophilus influenzae,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,,1,0,,,Activity,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,,,,
67386,67386,,Active,2502976,[],CHEMBL986858,Antibacterial activity against Moraxella catarrhalis,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,,1,0,,,Activity,,,,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Activity,,,,
67387,67387,,Active,2502977,[],CHEMBL986859,Antibacterial activity against Neisseria meningitidis,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,780131,,1,0,,,Activity,,,,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,Activity,,,,
67388,67388,,,2502978,[],CHEMBL986860,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780131,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,mg/L,UO_0000274,,32.0
67389,67389,,,2502979,[],CHEMBL986848,%T>MIC in methicillin-resistant Staphylococcus aureus in mouse thigh/lung infection model,A,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,780131,=,1,0,=,,T>MIC,%,,33.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,T>MIC,%,UO_0000187,,33.0
67390,67390,,,2502980,[],CHEMBL986849,%T>MIC in methicillin-resistant Staphylococcus aureus SA2 in mouse thigh/lung infection model,A,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,780131,=,1,0,=,,T>MIC,%,,75.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,T>MIC,%,UO_0000187,,75.0
67391,67391,,,2502981,[],CHEMBL986850,%T>MIC in vancomycin-intermediate Staphylococcus aureus in mouse thigh/lung infection model,A,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,780131,=,1,0,=,,T>MIC,%,,62.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,T>MIC,%,UO_0000187,,62.0
67392,67392,,,2502982,[],CHEMBL986851,Half life in rabbit,A,,,BAO_0002115,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,780131,<,1,1,<,,T1/2,hr,,0.3333,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,t1/2,min,UO_0000032,,20.0
67393,67393,,,2502983,[],CHEMBL986852,Protein binding in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,780131,<,1,1,<,,PPB,%,,20.0,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PPB,%,UO_0000187,,20.0
67394,67394,,,2502984,[],CHEMBL986853,Protein binding in rabbit plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1143426,Antimicrob Agents Chemother,2007.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,780131,<,1,1,<,,PPB,%,,20.0,CHEMBL613450,Oryctolagus cuniculus,Plasma,9986.0,,,PPB,%,UO_0000187,,20.0
67395,67395,,,3389042,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1216454,AUC (0 to infinity) in im dosed rat administered as single dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002120,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,930051,=,1,1,=,,AUC,ng.hr.mL-1,,37400.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,hr.microg/ml,,,37.4
67396,67396,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3389043,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1216455,Cmax in im dosed rat administered as single dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/Nanomolar,930051,=,1,1,=,,Cmax,nM,,37242.59,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,25.5
67397,67397,,,3389044,[],CHEMBL1216456,Terminal half life in im dosed rat administered as single dose by LC/MS/MS analysis,A,,,BAO_0002115,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,T1/2,hr,,0.621,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,beta t1/2,hr,UO_0000032,,0.621
67398,67398,,,3389045,[],CHEMBL1216457,Tmax in im dosed rat administered as single dose by LC/MS/MS analysis,A,,,BAO_0003037,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,Tmax,hr,,0.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Tmax,hr,UO_0000032,,0.5
67399,67399,,,3389046,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1216458,AUC (0 to infinity) in im dosed rabbit administered as single dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002120,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,930051,=,1,1,=,,AUC,ng.hr.mL-1,,39700.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,hr.microg/ml,,,39.7
67400,67400,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3389047,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1216459,Cmax in im dosed rabbit administered as single dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/Nanomolar,930051,=,1,1,=,,Cmax,nM,,37680.74,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmax,ug ml-1,UO_0000065,,25.8
67401,67401,,,3389048,[],CHEMBL1216460,Terminal half life in im dosed rabbit administered as single dose by LC/MS/MS analysis,A,,,BAO_0002115,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,T1/2,hr,,0.833,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,beta t1/2,hr,UO_0000032,,0.833
67402,67402,,,3389049,[],CHEMBL1216461,Tmax in im dosed rabbit administered as single dose by LC/MS/MS analysis,A,,,BAO_0003037,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,Tmax,hr,,0.438,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Tmax,hr,UO_0000032,,0.438
67403,67403,,,3389050,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1216462,AUC (0 to infinity) in im dosed monkey administered as single dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002120,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,930051,=,1,1,=,,AUC,ng.hr.mL-1,,72100.0,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,AUC,hr.microg/ml,,,72.1
67404,67404,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3389051,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1216463,Cmax in im dosed monkey administered as single dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/Nanomolar,930051,=,1,1,=,,Cmax,nM,,37388.64,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,Cmax,ug ml-1,UO_0000065,,25.6
67405,67405,,,3389052,[],CHEMBL1216464,Terminal half life im dosed monkey administered as single dose by LC/MS/MS analysis,A,,,BAO_0002115,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,T1/2,hr,,1.17,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,beta t1/2,hr,UO_0000032,,1.17
67406,67406,,,3389053,[],CHEMBL1216465,Tmax in im dosed monkey administered as single dose by LC/MS/MS analysis,A,,,BAO_0003037,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,Tmax,hr,,0.5,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,Tmax,hr,UO_0000032,,0.5
67407,67407,,,3389054,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1216466,AUC (0 to infinity) in iv dosed rat administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002120,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,930051,=,1,1,=,,AUC,ng.hr.mL-1,,16300.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,hr.microg/ml,,,16.3
67408,67408,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3389055,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1216467,Cmax in iv dosed rat administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/Nanomolar,930051,=,1,1,=,,Cmax,nM,,39579.38,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,27.1
67409,67409,,,3389056,[],CHEMBL1216468,Terminal half life in iv dosed rat administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002115,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,T1/2,hr,,0.426,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,beta t1/2,hr,UO_0000032,,0.426
67410,67410,,,3389057,[],CHEMBL1216469,Tmax in iv dosed rat administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0003037,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,Tmax,hr,,0.083,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Tmax,hr,UO_0000032,,0.083
67411,67411,,,3389058,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1216470,AUC (0 to infinity) in iv dosed rabbit administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002120,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,930051,=,1,1,=,,AUC,ng.hr.mL-1,,37000.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,hr.microg/ml,,,37.0
67412,67412,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3389059,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1216471,Cmax in iv dosed rabbit administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/Nanomolar,930051,=,1,1,=,,Cmax,nM,,99021.47,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmax,ug ml-1,UO_0000065,,67.8
67413,67413,,,3389060,[],CHEMBL1216472,Terminal half life in iv dosed rabbit administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002115,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,T1/2,hr,,0.41,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,beta t1/2,hr,UO_0000032,,0.41
67414,67414,,,3389061,[],CHEMBL1216473,Tmax in iv dosed rabbit administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0003037,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,Tmax,hr,,0.083,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Tmax,hr,UO_0000032,,0.083
67415,67415,,,3389062,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1216474,AUC (0 to infinity) in iv dosed monkey administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002120,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,930051,=,1,1,=,,AUC,ng.hr.mL-1,,64000.0,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,AUC,hr.microg/ml,,,64.0
67416,67416,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3389063,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1216475,Cmax in iv dosed monkey administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/Nanomolar,930051,=,1,1,=,,Cmax,nM,,100920.11,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,Cmax,ug ml-1,UO_0000065,,69.1
67417,67417,,,3389064,[],CHEMBL1216476,Terminal half life in iv dosed monkey administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0002115,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,T1/2,hr,,1.16,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,beta t1/2,hr,UO_0000032,,1.16
67418,67418,,,3389065,[],CHEMBL1216477,Tmax in iv dosed monkey administered as single bolus dose measured after 8 hrs by LC/MS/MS analysis,A,,,BAO_0003037,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Hour,930051,=,1,1,=,,Tmax,hr,,0.083,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,Tmax,hr,UO_0000032,,0.083
67419,67419,,,3389066,[],CHEMBL1216478,%T>MIC in Streptococcus pneumoniae-infected neutropenic mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,930051,=,1,0,=,,fT>MIC,%,,39.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,39.0
67420,67420,,,3389067,[],CHEMBL1216479,%T>MIC in Staphylococcus aureus-infected neutropenic mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,930051,=,1,0,=,,fT>MIC,%,,26.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,26.0
67421,67421,,,3389068,[],CHEMBL1216480,%T>MIC in gram negative bacteria-infected neutropenic mouse model,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,930051,=,1,0,=,,fT>MIC,%,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,32.0
67422,67422,,,3389069,[],CHEMBL1216481,"%T>MIC in rabbit endocarditis model at 20 mg/kg, im administered as single dose measured after 8 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,930051,=,1,0,=,,fT>MIC,%,,46.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,46.3
67423,67423,,,3389070,[],CHEMBL1216482,"%T>MIC in rabbit endocarditis model at 20 mg/kg, im administered as single dose measured after 12 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,930051,=,1,0,=,,fT>MIC,%,,30.9,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,30.9
67424,67424,,,3389071,[],CHEMBL1216483,Antibacterial activity against Staphylococcus,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930051,<=,1,1,<=,,MIC90,ug.mL-1,,2.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,2.0
67425,67425,,,3389072,[],CHEMBL1216484,Antibacterial activity against Streptococcus pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930051,<=,1,1,<=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
67426,67426,,,3389073,[],CHEMBL1216485,Plasma protein binding in human at 600 mg/kg. im administered every 12 hrs,A,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,930051,=,1,1,=,,PPB,%,,20.0,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,PPB,%,UO_0000187,,20.0
67427,67427,,,3389074,[],CHEMBL1216486,%T>MIC human infected with Staphylococcus at 600 mg/kg. im administered every 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,930051,=,1,0,=,,fT>MIC,%,,64.65,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,64.65
67428,67428,,,3389075,[],CHEMBL1216487,Antibacterial activity against Staphylococcus infected in human,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1212792,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930051,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.12
67429,67429,,,3486287,[],CHEMBL1264723,Antimicrobial activity against Bacteroides fragilis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC50,ug ml-1,UO_0000274,,16.0
67430,67430,,,3486291,[],CHEMBL1264724,Antimicrobial activity against Bacteroides thetaiotaomicron under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC50,ug ml-1,UO_0000274,,64.0
67431,67431,,,3486295,[],CHEMBL1264725,Antimicrobial activity against Bacteroides fragilis spp. under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC50,ug ml-1,UO_0000274,,64.0
67432,67432,,,3486299,[],CHEMBL1264726,Antimicrobial activity against Bacteroides caccae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,MIC50,ug ml-1,UO_0000274,,64.0
67433,67433,,,3486303,[],CHEMBL1264866,Antimicrobial activity against Bacteroides distasonis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC50,ug ml-1,UO_0000274,,64.0
67434,67434,,,3486307,[],CHEMBL1264867,Antimicrobial activity against Bacteroides merdae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,MIC50,ug ml-1,UO_0000274,,64.0
67435,67435,,,3486311,[],CHEMBL1264868,Antimicrobial activity against Bacteroides ovatus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC50,ug ml-1,UO_0000274,,64.0
67436,67436,,,3486315,[],CHEMBL1264869,Antimicrobial activity against Bacteroides uniformis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,MIC50,ug ml-1,UO_0000274,,64.0
67437,67437,,,3486319,[],CHEMBL1264870,Antimicrobial activity against Bacteroides vulgatus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,64.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC50,ug ml-1,UO_0000274,,64.0
67438,67438,,,3486323,[],CHEMBL1264871,Antimicrobial activity against Prevotella bivia under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC50,ug ml-1,UO_0000274,,2.0
67439,67439,,,3486327,[],CHEMBL1264872,Antimicrobial activity against Prevotella buccae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67440,67440,,,3486331,[],CHEMBL1264873,Antimicrobial activity against Prevotella melaninogenica under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC50,ug ml-1,UO_0000274,,2.0
67441,67441,,,3486335,[],CHEMBL1264874,Antimicrobial activity against Prevotella intermedia under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC50,ug ml-1,UO_0000274,,1.0
67442,67442,,,3486339,[],CHEMBL1264875,Antimicrobial activity against Prevotella bergensis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,2.0
67443,67443,,,3486343,[],CHEMBL1264876,Antimicrobial activity against Prevotella corporis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,,MIC50,ug ml-1,UO_0000274,,2.0
67444,67444,,,3486347,[],CHEMBL1264877,Antimicrobial activity against Prevotella denticola under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL615062,Prevotella denticola,Prevotella denticola,28129.0,,,MIC50,ug ml-1,UO_0000274,,2.0
67445,67445,,,3486351,[],CHEMBL1264878,Antimicrobial activity against Prevotella disiens under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,,MIC50,ug ml-1,UO_0000274,,2.0
67446,67446,,,3486355,[],CHEMBL1264879,Antimicrobial activity against Prevotella loescheii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,,MIC50,ug ml-1,UO_0000274,,2.0
67447,67447,,,3486359,[],CHEMBL1264880,Antimicrobial activity against Prevotella nanceiensis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,2.0
67448,67448,,,3486363,[],CHEMBL1264881,Antimicrobial activity against Prevotella oris under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,2.0
67449,67449,,,3486367,[],CHEMBL1264882,Antimicrobial activity against Prevotella tannerae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,2.0
67450,67450,,,3486371,[],CHEMBL1264883,Antimicrobial activity against Porphyromonas asaccharolyticus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL615058,Porphyromonas asaccharolytica,Porphyromonas asaccharolytica,28123.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67451,67451,,,3486375,[],CHEMBL1264884,Antimicrobial activity against Porphyromonas somerae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL615060,Porphyromonas somerae,Porphyromonas somerae,322095.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67452,67452,,,3486379,[],CHEMBL1264885,Antimicrobial activity against Fusobacterium nucleatum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,<=,1,1,<=,,MIC50,ug.mL-1,,0.08,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC50,ug ml-1,UO_0000274,,0.08
67453,67453,,,3486383,[],CHEMBL1264886,Antimicrobial activity against Fusobacterium necrophorum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,,MIC50,ug ml-1,UO_0000274,,0.03
67454,67454,,,3486387,[],CHEMBL1264887,Antimicrobial activity against Fusobacterium mortiferum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,,MIC50,ug ml-1,UO_0000274,,8.0
67455,67455,,,3486391,[],CHEMBL1264888,Antimicrobial activity against Fusobacterium varium under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,,MIC50,ug ml-1,UO_0000274,,0.25
67456,67456,,,3486395,[],CHEMBL1264889,Antimicrobial activity against Veillonella spp. under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL4888482,Veillonella,Veillonella,29465.0,,,MIC50,ug ml-1,UO_0000274,,0.125
67457,67457,,,3486399,[],CHEMBL1264890,Antimicrobial activity against Anaerococcus prevotii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,,MIC50,ug ml-1,UO_0000274,,0.03
67458,67458,,,3486403,[],CHEMBL1264891,Antimicrobial activity against Anaerococcus tetradius under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,,MIC50,ug ml-1,UO_0000274,,0.03
67459,67459,,,3486407,[],CHEMBL1264892,Antimicrobial activity against Finegoldia magna under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC50,ug ml-1,UO_0000274,,0.25
67460,67460,,,3486411,[],CHEMBL1264893,Antimicrobial activity against Parvimonas micra under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC50,ug ml-1,UO_0000274,,0.06
67461,67461,,,3486415,[],CHEMBL1264894,Antimicrobial activity against Peptoniphilus asaccharolyticus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC50,ug ml-1,UO_0000274,,0.06
67462,67462,,,3486419,[],CHEMBL1264895,Antimicrobial activity against Peptostreptococcus anaerobius under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67463,67463,,,3486423,[],CHEMBL1264896,Antimicrobial activity against Peptostreptococcus stomatis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
67464,67464,,,3486427,[],CHEMBL1264897,Antimicrobial activity against Anaerococcus lactolyticus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
67465,67465,,,3486431,[],CHEMBL1264898,Antimicrobial activity against Anaerococcus murdochii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
67466,67466,,,3486435,[],CHEMBL1264899,Antimicrobial activity against Anaerococcus octavius under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
67467,67467,,,3486439,[],CHEMBL1264900,Antimicrobial activity against Anaerococcus vaginalis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614748,Anaerococcus vaginalis,Anaerococcus vaginalis,33037.0,,,MIC50,ug ml-1,UO_0000274,,0.06
67468,67468,,,3486443,[],CHEMBL1264901,Antimicrobial activity against Anaerococcus sp. under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
67469,67469,,,3487203,[],CHEMBL1264902,Antimicrobial activity against Gemella morbillorum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
67470,67470,,,3487207,[],CHEMBL1264903,Antimicrobial activity against Gemella sanguinis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
67471,67471,,,3487211,[],CHEMBL1264904,Antimicrobial activity against Peptoniphilus harei under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
67472,67472,,,3487215,[],CHEMBL1264905,Antimicrobial activity against Peptoniphilus lacrimalis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
67473,67473,,,3487219,[],CHEMBL1264906,Antimicrobial activity against Actinomyces israelii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL614976,Actinomyces israelii,Actinomyces israelii,1659.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67474,67474,,,3487223,[],CHEMBL1265026,Antimicrobial activity against Actinomyces meyeri under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67475,67475,,,3487227,[],CHEMBL1265027,Antimicrobial activity against Actinomyces neuii subsp. anitratus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.015
67476,67476,,,3487231,[],CHEMBL1265028,Antimicrobial activity against Actinomyces odontolyticus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.015
67477,67477,,,3487235,[],CHEMBL1265029,Antimicrobial activity against Actinomyces turicensis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.015
67478,67478,,,3487239,[],CHEMBL1265030,Antimicrobial activity against Propionibacterium acnes under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,<=,1,1,<=,,MIC50,ug.mL-1,,0.008,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC50,ug ml-1,UO_0000274,,0.008
67479,67479,,,3487243,[],CHEMBL1265031,Antimicrobial activity against Propionibacterium avidum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.25
67480,67480,,,3487247,[],CHEMBL1265032,Antimicrobial activity against Eggerthella lenta under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,,MIC50,ug ml-1,UO_0000274,,8.0
67481,67481,,,3487251,[],CHEMBL1265033,Antimicrobial activity against Atopobium parvulum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.125
67482,67482,,,3487255,[],CHEMBL1265034,Antimicrobial activity against Colinsella aerofaciens under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,,MIC50,ug ml-1,UO_0000274,,0.125
67483,67483,,,3487259,[],CHEMBL1265035,Antimicrobial activity against Eubacterium contortum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.125
67484,67484,,,3487263,[],CHEMBL1265036,Antimicrobial activity against Eubacterium cylindroides under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.125
67485,67485,,,3487267,[],CHEMBL1265715,Antimicrobial activity against Eubacterium limosum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL613084,Eubacterium limosum,Eubacterium limosum,1736.0,,,MIC50,ug ml-1,UO_0000274,,0.125
67486,67486,,,3487271,[],CHEMBL1265038,Antimicrobial activity against Eubacterium saburreum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.125
67487,67487,,,3487275,[],CHEMBL1265039,Antimicrobial activity against Mogibacterium timidum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.125
67488,67488,,,3487279,[],CHEMBL1265040,Antimicrobial activity against Slackia exigua under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.125
67489,67489,,,3487283,[],CHEMBL1265041,Antimicrobial activity against Solobacterium moorei under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.125
67490,67490,,,3487287,[],CHEMBL1265042,Antimicrobial activity against Lactobacillus casei under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL613075,Lacticaseibacillus casei,Lacticaseibacillus casei,1582.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67491,67491,,,3487291,[],CHEMBL1265043,Antimicrobial activity against Lactobacillus rhamnosus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL2366698,Lacticaseibacillus rhamnosus,Lacticaseibacillus rhamnosus,47715.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67492,67492,,,3487295,[],CHEMBL1265044,Antimicrobial activity against Clostridium perfringens under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC50,ug ml-1,UO_0000274,,0.125
67493,67493,,,3487299,[],CHEMBL1265045,Antimicrobial activity against Clostridium ramosum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC50,ug ml-1,UO_0000274,,1.0
67494,67494,,,3487303,[],CHEMBL1265046,Antimicrobial activity against Clostridium inoculum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,,MIC50,ug ml-1,UO_0000274,,1.0
67495,67495,,,3487307,[],CHEMBL1265047,Antimicrobial activity against Clostridium clostridioforme under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,,MIC50,ug ml-1,UO_0000274,,1.0
67496,67496,,,3487311,[],CHEMBL1265048,Antimicrobial activity against Clostridium aldenense under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
67497,67497,,,3487315,[],CHEMBL1265049,Antimicrobial activity against Clostridium bolteae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
67498,67498,,,3487319,[],CHEMBL1265050,Antimicrobial activity against Clostridium citroniae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
67499,67499,,,3487323,[],CHEMBL1265051,Antimicrobial activity against Clostridium hathewayi under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
67500,67500,,,3487327,[],CHEMBL1265052,Antimicrobial activity against Clostridium baratii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
67501,67501,,,3487331,[],CHEMBL1265053,Antimicrobial activity against Clostridium bifermentans under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67502,67502,,,3487335,[],CHEMBL1265054,Antimicrobial activity against Clostridium butyricum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67503,67503,,,3487339,[],CHEMBL1265055,Antimicrobial activity against Clostridium cadaveris under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614970,Clostridium cadaveris,Clostridium cadaveris,1529.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67504,67504,,,3487343,[],CHEMBL1265056,Antimicrobial activity against Clostridium celerecrescens under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
67505,67505,,,3487347,[],CHEMBL1265057,Antimicrobial activity against Clostridium difficile under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67506,67506,,,3487351,[],CHEMBL1265058,Antimicrobial activity against Clostridium glycolicum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
67507,67507,,,3487355,[],CHEMBL1265059,Antimicrobial activity against Clostridium hylemonae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
67508,67508,,,3487359,[],CHEMBL1265060,Antimicrobial activity against Clostridium paraputrificum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67509,67509,,,3487363,[],CHEMBL1265061,Antimicrobial activity against Clostridium sordellii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67510,67510,,,3487367,[],CHEMBL1265062,Antimicrobial activity against Clostridium sphenoides under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL615028,Lacrimispora sphenoides,Lacrimispora sphenoides,29370.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67511,67511,,,3487371,[],CHEMBL1265063,Antimicrobial activity against Clostridium subterminale under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
67512,67512,,,3487375,[],CHEMBL1265064,Antimicrobial activity against Clostridium symbiosum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
67513,67513,,,3487379,[],CHEMBL1265065,Antimicrobial activity against Clostridium tertium under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67514,67514,,,3487383,[],CHEMBL1264723,Antimicrobial activity against Bacteroides fragilis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67515,67515,,,3487387,[],CHEMBL1264724,Antimicrobial activity against Bacteroides thetaiotaomicron under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67516,67516,,,3487391,[],CHEMBL1264725,Antimicrobial activity against Bacteroides fragilis spp. under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67517,67517,,,3487395,[],CHEMBL1264726,Antimicrobial activity against Bacteroides caccae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67518,67518,,,3487399,[],CHEMBL1264866,Antimicrobial activity against Bacteroides distasonis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67519,67519,,,3487403,[],CHEMBL1264867,Antimicrobial activity against Bacteroides merdae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67520,67520,,,3487407,[],CHEMBL1264868,Antimicrobial activity against Bacteroides ovatus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67521,67521,,,3487411,[],CHEMBL1264869,Antimicrobial activity against Bacteroides uniformis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67522,67522,,,3487415,[],CHEMBL1264870,Antimicrobial activity against Bacteroides vulgatus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67523,67523,,,3487419,[],CHEMBL1264871,Antimicrobial activity against Prevotella bivia under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67524,67524,,,3487423,[],CHEMBL1264872,Antimicrobial activity against Prevotella buccae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC90,ug ml-1,UO_0000274,,64.0
67525,67525,,,3487427,[],CHEMBL1264873,Antimicrobial activity against Prevotella melaninogenica under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67526,67526,,,3487431,[],CHEMBL1264874,Antimicrobial activity against Prevotella intermedia under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67527,67527,,,3487435,[],CHEMBL1264875,Antimicrobial activity against Prevotella bergensis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
67528,67528,,,3487439,[],CHEMBL1264876,Antimicrobial activity against Prevotella corporis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67529,67529,,,3487443,[],CHEMBL1264877,Antimicrobial activity against Prevotella denticola under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL615062,Prevotella denticola,Prevotella denticola,28129.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67530,67530,,,3487447,[],CHEMBL1264878,Antimicrobial activity against Prevotella disiens under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67531,67531,,,3487451,[],CHEMBL1264879,Antimicrobial activity against Prevotella loescheii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67532,67532,,,3487455,[],CHEMBL1264880,Antimicrobial activity against Prevotella nanceiensis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
67533,67533,,,3487459,[],CHEMBL1264881,Antimicrobial activity against Prevotella oris under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
67534,67534,,,3487463,[],CHEMBL1264882,Antimicrobial activity against Prevotella tannerae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
67535,67535,,,3487467,[],CHEMBL1264883,Antimicrobial activity against Porphyromonas asaccharolyticus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL615058,Porphyromonas asaccharolytica,Porphyromonas asaccharolytica,28123.0,,,MIC90,ug ml-1,UO_0000274,,0.03
67536,67536,,,3487471,[],CHEMBL1264884,Antimicrobial activity against Porphyromonas somerae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL615060,Porphyromonas somerae,Porphyromonas somerae,322095.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67537,67537,,,3487475,[],CHEMBL1264885,Antimicrobial activity against Fusobacterium nucleatum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC90,ug ml-1,UO_0000274,,0.125
67538,67538,,,3487479,[],CHEMBL1264886,Antimicrobial activity against Fusobacterium necrophorum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,,MIC90,ug ml-1,UO_0000274,,0.06
67539,67539,,,3487483,[],CHEMBL1264887,Antimicrobial activity against Fusobacterium mortiferum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67540,67540,,,3487487,[],CHEMBL1264888,Antimicrobial activity against Fusobacterium varium under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67541,67541,,,3487491,[],CHEMBL1264889,Antimicrobial activity against Veillonella spp. under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL4888482,Veillonella,Veillonella,29465.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67542,67542,,,3487495,[],CHEMBL1264890,Antimicrobial activity against Anaerococcus prevotii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,,MIC90,ug ml-1,UO_0000274,,0.125
67543,67543,,,3487499,[],CHEMBL1264891,Antimicrobial activity against Anaerococcus tetradius under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL614747,Anaerococcus tetradius,Anaerococcus tetradius,33036.0,,,MIC90,ug ml-1,UO_0000274,,0.125
67544,67544,,,3487503,[],CHEMBL1264892,Antimicrobial activity against Finegoldia magna under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67545,67545,,,3487507,[],CHEMBL1264893,Antimicrobial activity against Parvimonas micra under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67546,67546,,,3487511,[],CHEMBL1264894,Antimicrobial activity against Peptoniphilus asaccharolyticus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67547,67547,,,3487515,[],CHEMBL1264895,Antimicrobial activity against Peptostreptococcus anaerobius under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC90,ug ml-1,UO_0000274,,4.0
67548,67548,,,3487519,[],CHEMBL1264896,Antimicrobial activity against Peptostreptococcus stomatis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,4.0
67549,67549,,,3487523,[],CHEMBL1264897,Antimicrobial activity against Anaerococcus lactolyticus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
67550,67550,,,3487527,[],CHEMBL1264898,Antimicrobial activity against Anaerococcus murdochii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
67551,67551,,,3487531,[],CHEMBL1264899,Antimicrobial activity against Anaerococcus octavius under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
67552,67552,,,3487535,[],CHEMBL1264900,Antimicrobial activity against Anaerococcus vaginalis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614748,Anaerococcus vaginalis,Anaerococcus vaginalis,33037.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67553,67553,,,3488327,[],CHEMBL1264901,Antimicrobial activity against Anaerococcus sp. under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
67554,67554,,,3488331,[],CHEMBL1264902,Antimicrobial activity against Gemella morbillorum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
67555,67555,,,3488335,[],CHEMBL1264903,Antimicrobial activity against Gemella sanguinis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
67556,67556,,,3488339,[],CHEMBL1264904,Antimicrobial activity against Peptoniphilus harei under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
67557,67557,,,3488343,[],CHEMBL1264905,Antimicrobial activity against Peptoniphilus lacrimalis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
67558,67558,,,3488347,[],CHEMBL1264906,Antimicrobial activity against Actinomyces israelii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614976,Actinomyces israelii,Actinomyces israelii,1659.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67559,67559,,,3488351,[],CHEMBL1265026,Antimicrobial activity against Actinomyces meyeri under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67560,67560,,,3488355,[],CHEMBL1265027,Antimicrobial activity against Actinomyces neuii subsp. anitratus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67561,67561,,,3488359,[],CHEMBL1265028,Antimicrobial activity against Actinomyces odontolyticus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67562,67562,,,3488363,[],CHEMBL1265029,Antimicrobial activity against Actinomyces turicensis under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67563,67563,,,3488367,[],CHEMBL1265030,Antimicrobial activity against Propionibacterium acnes under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC90,ug ml-1,UO_0000274,,0.06
67564,67564,,,3488371,[],CHEMBL1265031,Antimicrobial activity against Propionibacterium avidum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67565,67565,,,3488375,[],CHEMBL1265032,Antimicrobial activity against Eggerthella lenta under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67566,67566,,,3488379,[],CHEMBL1265033,Antimicrobial activity against Atopobium parvulum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67567,67567,,,3488383,[],CHEMBL1265034,Antimicrobial activity against Colinsella aerofaciens under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL612692,Collinsella aerofaciens,Collinsella aerofaciens,74426.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67568,67568,,,3488387,[],CHEMBL1265035,Antimicrobial activity against Eubacterium contortum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67569,67569,,,3488391,[],CHEMBL1265036,Antimicrobial activity against Eubacterium cylindroides under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67570,67570,,,3488395,[],CHEMBL1265715,Antimicrobial activity against Eubacterium limosum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL613084,Eubacterium limosum,Eubacterium limosum,1736.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67571,67571,,,3488399,[],CHEMBL1265038,Antimicrobial activity against Eubacterium saburreum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67572,67572,,,3488403,[],CHEMBL1265039,Antimicrobial activity against Mogibacterium timidum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67573,67573,,,3488407,[],CHEMBL1265040,Antimicrobial activity against Slackia exigua under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67574,67574,,,3488411,[],CHEMBL1265041,Antimicrobial activity against Solobacterium moorei under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
67575,67575,,,3488415,[],CHEMBL1265042,Antimicrobial activity against Lactobacillus casei under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL613075,Lacticaseibacillus casei,Lacticaseibacillus casei,1582.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67576,67576,,,3488419,[],CHEMBL1265043,Antimicrobial activity against Lactobacillus rhamnosus under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL2366698,Lacticaseibacillus rhamnosus,Lacticaseibacillus rhamnosus,47715.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67577,67577,,,3488423,[],CHEMBL1265044,Antimicrobial activity against Clostridium perfringens under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67578,67578,,,3488427,[],CHEMBL1265045,Antimicrobial activity against Clostridium ramosum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67579,67579,,,3488431,[],CHEMBL1265046,Antimicrobial activity against Clostridium inoculum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,,MIC90,ug ml-1,UO_0000274,,2.0
67580,67580,,,3488435,[],CHEMBL1265047,Antimicrobial activity against Clostridium clostridioforme under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,,MIC90,ug ml-1,UO_0000274,,2.0
67581,67581,,,3488439,[],CHEMBL1265048,Antimicrobial activity against Clostridium aldenense under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
67582,67582,,,3488443,[],CHEMBL1265049,Antimicrobial activity against Clostridium bolteae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
67583,67583,,,3488447,[],CHEMBL1265050,Antimicrobial activity against Clostridium citroniae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
67584,67584,,,3488451,[],CHEMBL1265051,Antimicrobial activity against Clostridium hathewayi under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
67585,67585,,,3488455,[],CHEMBL1265052,Antimicrobial activity against Clostridium baratii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,16.0
67586,67586,,,3488459,[],CHEMBL1265053,Antimicrobial activity against Clostridium bifermentans under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67587,67587,,,3488463,[],CHEMBL1265054,Antimicrobial activity against Clostridium butyricum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67588,67588,,,3488467,[],CHEMBL1265055,Antimicrobial activity against Clostridium cadaveris under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614970,Clostridium cadaveris,Clostridium cadaveris,1529.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67589,67589,,,3488471,[],CHEMBL1265056,Antimicrobial activity against Clostridium celerecrescens under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,16.0
67590,67590,,,3488475,[],CHEMBL1265057,Antimicrobial activity against Clostridium difficile under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67591,67591,,,3488479,[],CHEMBL1265058,Antimicrobial activity against Clostridium glycolicum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,16.0
67592,67592,,,3488483,[],CHEMBL1265059,Antimicrobial activity against Clostridium hylemonae under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,16.0
67593,67593,,,3488487,[],CHEMBL1265060,Antimicrobial activity against Clostridium paraputrificum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67594,67594,,,3488491,[],CHEMBL1265061,Antimicrobial activity against Clostridium sordellii under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67595,67595,,,3488495,[],CHEMBL1265062,Antimicrobial activity against Clostridium sphenoides under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL615028,Lacrimispora sphenoides,Lacrimispora sphenoides,29370.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67596,67596,,,3488499,[],CHEMBL1265063,Antimicrobial activity against Clostridium subterminale under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,16.0
67597,67597,,,3488503,[],CHEMBL1265064,Antimicrobial activity against Clostridium symbiosum under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,16.0
67598,67598,,,3488507,[],CHEMBL1265065,Antimicrobial activity against Clostridium tertium under anaerobic conditions after 44 hrs by CLSI-M11-47 protocol based agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255409,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959662,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67599,67599,,,3492960,[],CHEMBL1262782,Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL and mec type IV gene by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958659,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67600,67600,,,3492972,[],CHEMBL1262782,Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL and mec type IV gene by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958659,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67601,67601,,,3492984,[],CHEMBL1262782,Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL and mec type IV gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958659,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67602,67602,,,3492995,[],CHEMBL1262786,Antimicrobial activity against non-extended-spectrum beta-lactamase producing Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958659,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,0.12
67603,67603,,,3492996,[],CHEMBL1262787,Antimicrobial activity against Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958659,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67604,67604,,,3492997,[],CHEMBL1262788,Antimicrobial activity against Morganella morganii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958659,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC90,ug ml-1,UO_0000274,,0.12
67605,67605,,,3492998,[],CHEMBL1262789,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958659,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,0.12
67606,67606,,,3492999,[],CHEMBL1262790,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958659,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,2.0
67607,67607,,,3494069,[],CHEMBL1262785,Antimicrobial activity against Citrobacter freundii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958659,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC90,ug ml-1,UO_0000274,,2.0
67608,67608,,,3509331,[],CHEMBL1266938,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 1564 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
67609,67609,,,3509332,[],CHEMBL1266939,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 2688 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
67610,67610,,,3509333,[],CHEMBL1266940,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 1394 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
67611,67611,,,3509334,[],CHEMBL1266941,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 24 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
67612,67612,,,3509335,[],CHEMBL1266942,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 3413 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67613,67613,,,3509336,[],CHEMBL1266943,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 2527 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
67614,67614,,,3509337,[],CHEMBL1266944,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae 1076 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
67615,67615,,,3509338,[],CHEMBL1266945,"Antibacterial activity against methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67616,67616,,,3509339,[],CHEMBL1266946,"Antibacterial activity against methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67617,67617,,,3509340,[],CHEMBL1266947,"Antibacterial activity against methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
67618,67618,,,3509341,[],CHEMBL1266948,"Antibacterial activity against methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67619,67619,,,3509342,[],CHEMBL1266949,"Antibacterial activity against methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67620,67620,,,3509343,[],CHEMBL1266950,"Antibacterial activity against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67621,67621,,,3509344,[],CHEMBL1266951,"Binding affinity to methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 PBP1 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.5,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.5
67622,67622,,,3509345,[],CHEMBL1266952,"Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP1 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,8.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,8.0
67623,67623,,,3509346,[],CHEMBL1266953,"Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP1 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.5,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.5
67624,67624,,,3509347,[],CHEMBL1266954,"Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP1 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,1.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,1.0
67625,67625,,,3509348,[],CHEMBL1266955,"Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP1 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.125,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.125
67626,67626,,,3509349,[],CHEMBL1266956,"Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP1 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.5,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.5
67627,67627,,,3509350,[],CHEMBL1266957,"Binding affinity to methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 PBP2 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67628,67628,,,3509351,[],CHEMBL1266958,"Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP2 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.5,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.5
67629,67629,,,3509352,[],CHEMBL1266959,"Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP2 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.125,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.125
67630,67630,,,3509353,[],CHEMBL1266960,"Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP2 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,1.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,1.0
67631,67631,,,3509354,[],CHEMBL1266961,"Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP2 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,4.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,4.0
67632,67632,,,3509355,[],CHEMBL1266962,"Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP2 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67633,67633,,,3509356,[],CHEMBL1266963,"Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP2a by competitive binding assay",B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.5,CHEMBL6187,Staphylococcus aureus,MecA,1280.0,,,IC50,ug ml-1,UO_0000274,,0.5
67634,67634,,,3509357,[],CHEMBL1266964,"Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP2a by competitive binding assay",B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL6187,Staphylococcus aureus,MecA,1280.0,,,IC50,ug ml-1,UO_0000274,,0.25
67635,67635,,,3509358,[],CHEMBL1266965,"Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP2a by competitive binding assay",B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,1.0,CHEMBL6187,Staphylococcus aureus,MecA,1280.0,,,IC50,ug ml-1,UO_0000274,,1.0
67636,67636,,,3509359,[],CHEMBL1267048,"Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP2a by competitive binding assay",B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,1.0,CHEMBL6187,Staphylococcus aureus,MecA,1280.0,,,IC50,ug ml-1,UO_0000274,,1.0
67637,67637,,,3509360,[],CHEMBL1267049,"Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP2a by competitive binding assay",B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.01,CHEMBL6187,Staphylococcus aureus,MecA,1280.0,,,IC50,ug ml-1,UO_0000274,,0.01
67638,67638,,,3509361,[],CHEMBL1267050,"Binding affinity to methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 PBP3 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.125,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.125
67639,67639,,,3509362,[],CHEMBL1267051,"Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP3 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.125,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.125
67640,67640,,,3509363,[],CHEMBL1267052,"Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP3 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.125,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.125
67641,67641,,,3509364,[],CHEMBL1267053,"Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP3 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.5,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.5
67642,67642,,,3509365,[],CHEMBL1267054,"Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP3 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.1
67643,67643,,,3509366,[],CHEMBL1267055,"Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP3 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67644,67644,,,3509367,[],CHEMBL1267056,"Binding affinity to methicillin-, vancomycin-susceptible Staphylococcus aureus ATCC 29213 PBP4 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,>,1,1,>,,IC50,ug.mL-1,,8.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,8.0
67645,67645,,,3509368,[],CHEMBL1267057,"Binding affinity to methicillin-resistant, heteroresistant vancomycin-intermediate, beta-lactamase-negative Staphylococcus aureus 873 PBP4 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,>,1,1,>,,IC50,ug.mL-1,,128.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,128.0
67646,67646,,,3509369,[],CHEMBL1267058,"Binding affinity to methicillin-, vancomycin-resistant, beta-lactamase-positive Staphylococcus aureus 510 PBP4 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,>,1,1,>,,IC50,ug.mL-1,,128.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,128.0
67647,67647,,,3509370,[],CHEMBL1267059,"Binding affinity to methicillin-, linezolid-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 2149A PBP4 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,>,1,1,>,,IC50,ug.mL-1,,128.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,128.0
67648,67648,,,3509371,[],CHEMBL1267060,"Binding affinity to methicillin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 1287 PBP4 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,64.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,64.0
67649,67649,,Not Determined,3509372,[],CHEMBL1267447,"Binding affinity to against methicillin-, daptomycin-resistant, vancomycin-intermediate, beta-lactamase-positive Staphylococcus aureus 25 PBP4 by competitive binding assay",B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,957721,,1,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
67650,67650,,,3509373,[],CHEMBL1267448,Binding affinity to against penicillin-susceptible Streptococcus pneumoniae 1076 PBP1A by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL1255141,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 1A,170187.0,,,IC50,ug ml-1,UO_0000274,,0.25
67651,67651,,,3509374,[],CHEMBL1267449,Binding affinity to penicillin-resistant Streptococcus pneumoniae 24 PBP1A by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.125,CHEMBL1255141,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 1A,170187.0,,,IC50,ug ml-1,UO_0000274,,0.125
67652,67652,,,3509375,[],CHEMBL1267450,Binding affinity to penicillin-resistant Streptococcus pneumoniae 3413 PBP1A by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL1255141,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 1A,170187.0,,,IC50,ug ml-1,UO_0000274,,0.25
67653,67653,,,3509376,[],CHEMBL1267451,Binding affinity to penicillin-resistant Streptococcus pneumoniae 2527 PBP1A by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL1255141,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 1A,170187.0,,,IC50,ug ml-1,UO_0000274,,0.25
67654,67654,,,3509377,[],CHEMBL1267452,Binding affinity to against penicillin-susceptible Streptococcus pneumoniae 1076 PBP1B by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67655,67655,,,3509378,[],CHEMBL1267453,Binding affinity to penicillin-resistant Streptococcus pneumoniae 24 PBP1B by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.1
67656,67656,,,3509379,[],CHEMBL1267454,Binding affinity to penicillin-resistant Streptococcus pneumoniae 3413 PBP1B by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67657,67657,,,3509380,[],CHEMBL1267455,Binding affinity to penicillin-resistant Streptococcus pneumoniae 2527 PBP1B by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67658,67658,,,3509381,[],CHEMBL1267456,Binding affinity to against penicillin-susceptible Streptococcus pneumoniae 1076 PBP2X by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL6188,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2x,170187.0,,,IC50,ug ml-1,UO_0000274,,0.1
67659,67659,,,3509382,[],CHEMBL1267457,Binding affinity to penicillin-resistant Streptococcus pneumoniae 24 PBP2X by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,1.0,CHEMBL6188,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2x,170187.0,,,IC50,ug ml-1,UO_0000274,,1.0
67660,67660,,,3509383,[],CHEMBL1267458,Binding affinity to penicillin-resistant Streptococcus pneumoniae 3413 PBP2X by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL6188,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2x,170187.0,,,IC50,ug ml-1,UO_0000274,,0.25
67661,67661,,,3509384,[],CHEMBL1267459,Binding affinity to penicillin-resistant Streptococcus pneumoniae 2527 PBP2X by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL6188,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2x,170187.0,,,IC50,ug ml-1,UO_0000274,,0.1
67662,67662,,,3509385,[],CHEMBL1267460,Binding affinity to against penicillin-susceptible Streptococcus pneumoniae 1076 PBP2A by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67663,67663,,,3509386,[],CHEMBL1267461,Binding affinity to penicillin-resistant Streptococcus pneumoniae 24 PBP2A by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.5,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.5
67664,67664,,,3509387,[],CHEMBL1267462,Binding affinity to penicillin-resistant Streptococcus pneumoniae 3413 PBP2A by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67665,67665,,,3509388,[],CHEMBL1267463,Binding affinity to penicillin-resistant Streptococcus pneumoniae 2527 PBP2A by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67666,67666,,,3509389,[],CHEMBL1267464,Binding affinity to against penicillin-susceptible Streptococcus pneumoniae 1076 PBP2B by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,4.0,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,4.0
67667,67667,,,3509390,[],CHEMBL1267465,Binding affinity to penicillin-resistant Streptococcus pneumoniae 24 PBP2B by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.5,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,0.5
67668,67668,,,3509391,[],CHEMBL1267466,Binding affinity to penicillin-resistant Streptococcus pneumoniae 3413 PBP2B by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,2.0,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,2.0
67669,67669,,,3509392,[],CHEMBL1267467,Binding affinity to penicillin-resistant Streptococcus pneumoniae 2527 PBP2B by competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,4.0,CHEMBL1255133,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4),Penicillin-binding protein 2B,170187.0,,,IC50,ug ml-1,UO_0000274,,4.0
67670,67670,,,3509393,[],CHEMBL1267468,Binding affinity to against penicillin-susceptible Streptococcus pneumoniae 1076 PBP3 by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.1
67671,67671,,,3509394,[],CHEMBL1267469,Binding affinity to penicillin-resistant Streptococcus pneumoniae 24 PBP3 by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.1
67672,67672,,,3509395,[],CHEMBL1267470,Binding affinity to penicillin-resistant Streptococcus pneumoniae 3413 PBP3 by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.1
67673,67673,,,3509396,[],CHEMBL1267471,Binding affinity to penicillin-resistant Streptococcus pneumoniae 2527 PBP3 by competitive binding assay,B,,,BAO_0000190,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255453,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957721,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,0.25
67674,67674,,,3511020,[],CHEMBL1266312,"Plasma concentration in healthy human at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 2",A,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,=,1,0,=,,Cp,mg/L,,25.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,mg/L,,,25.9
67675,67675,,,3511021,[],CHEMBL1266313,"Plasma concentration in healthy human at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 5",A,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,=,1,0,=,,Cp,mg/L,,24.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,mg/L,,,24.5
67676,67676,,,3511022,[],CHEMBL1266314,"Plasma concentration in healthy human at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 7",A,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,=,1,0,=,,Cp,mg/L,,23.8,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,mg/L,,,23.8
67677,67677,,Not Active,3511023,[],CHEMBL1266315,"Antibacterial activity against Enterococcus in healthy human intestine at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 21",F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,,1,0,,,Activity,,,,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,Activity,,,,
67678,67678,,Not Active,3511024,[],CHEMBL1266316,"Antifungal activity against Candida albicans in healthy human intestine at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 21",F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,,1,0,,,Activity,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,Activity,,,,
67679,67679,,,3511025,[],CHEMBL1266317,"Antibacterial activity against Escherichia coli in healthy human intestine assessed as log reduction in bacterial count per gram of feces at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 7",F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,=,1,0,=,,log10cfu,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10cfu,,,,2.0
67680,67680,,,3511026,[],CHEMBL1266318,"Antibacterial activity against Escherichia coli in healthy human intestine assessed as log reduction in bacterial count per gram of feces at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 9",F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,=,1,0,=,,log10cfu,,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10cfu,,,,1.5
67681,67681,,Active,3511027,[],CHEMBL1266319,"Antibacterial activity against Escherichia coli in healthy human intestine assessed as decrease in bacterial count at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 14",F,,,BAO_0000201,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,958007,,1,0,,,Inhibition,%,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,INH,,UO_0000187,,
67682,67682,,Not Active,3511028,[],CHEMBL1266320,"Antibacterial activity against Enterobacteriaceae in healthy human intestine assessed as decrease in bacterial count at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 14",F,,,BAO_0000201,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,958007,,1,0,,,Inhibition,%,,,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,INH,,UO_0000187,,
67683,67683,,,3511029,[],CHEMBL1266321,"Antibacterial activity against Bifidobacterium in healthy human intestine assessed as log reduction in bacterial count per gram of feces at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 7",F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,=,1,0,=,,log10cfu,,,2.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,log10cfu,,,,2.1
67684,67684,,,3511030,[],CHEMBL1266322,"Antibacterial activity against Lactobacillus in healthy human intestine assessed as log reduction in bacterial count per gram of feces at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 7",F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,=,1,0,=,,log10cfu,,,1.7,CHEMBL3879801,,NON-PROTEIN TARGET,,,,log10cfu,,,,1.7
67685,67685,,Not Active,3511031,[],CHEMBL1266323,"Antibacterial activity against Clostridium in healthy human intestine assessed as decrease in bacterial count at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 7",F,,,BAO_0000201,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,958007,,1,0,,,Inhibition,%,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,INH,,UO_0000187,,
67686,67686,,Not Active,3511032,[],CHEMBL1266324,"Antibacterial activity against Bacteroides sp. in healthy human intestine assessed as decrease in bacterial count at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 21",F,,,BAO_0000201,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,958007,,1,0,,,Inhibition,%,,,CHEMBL613908,Bacteroides sp.,Bacteroides sp.,29523.0,,,INH,,UO_0000187,,
67687,67687,,Non-toxic,3511033,[],CHEMBL1266325,"Toxicity against healthy human assessed as effect on ECG parameters at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 9",T,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
67688,67688,,,3511034,[],CHEMBL1266326,Antibacterial activity against Bacteroides fragilis ATCC 25285 after 48 hrs by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958007,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,mg/L,UO_0000274,,64.0
67689,67689,,,3511035,[],CHEMBL1266454,Antibacterial activity against Clostridium difficile ATCC 700057 after 48 hrs by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958007,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,mg/L,UO_0000274,,4.0
67690,67690,,Active,3511036,[],CHEMBL1266455,Antibacterial activity against Staphylococcus aureus ATCC 29213 at =< 4 mg/L after 48 hrs by CLSI method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
67691,67691,,Active,3511037,[],CHEMBL1266456,Antibacterial activity against Enterococcus faecalis ATCC 29212 at =< 4 mg/L after 48 hrs by CLSI method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
67692,67692,,Active,3511038,[],CHEMBL1266457,Antibacterial activity against Escherichia coli ATCC 25922 at =< 4 mg/L after 48 hrs by CLSI method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
67693,67693,,Non-toxic,3511039,[],CHEMBL1266459,"Toxicity against healthy human assessed as effect on hematological parameters at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 9",T,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
67694,67694,,,3511040,[],CHEMBL1266460,Antibacterial activity against Propionibacterium by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958007,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614980,Propionibacterium,Propionibacterium,1743.0,,,MIC90,mg/L,UO_0000274,,4.0
67695,67695,,,3511041,[],CHEMBL1266461,Antibacterial activity against Peptostreptococcus sp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958007,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,,MIC90,mg/L,UO_0000274,,4.0
67696,67696,,,3511042,[],CHEMBL1266462,Antibacterial activity against Clostridium perfringens by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958007,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,mg/L,UO_0000274,,4.0
67697,67697,,,3511043,[],CHEMBL1264287,Antibacterial activity against Clostridium septicum by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958007,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,,MIC90,mg/L,UO_0000274,,4.0
67698,67698,,,3511044,[],CHEMBL1264288,Antibacterial activity against Clostridium difficile by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958007,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,mg/L,UO_0000274,,4.0
67699,67699,,,3511045,[],CHEMBL1266458,Antibacterial activity against Bacteroides fragilis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958007,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,mg/L,UO_0000274,,32.0
67700,67700,,,3511046,[],CHEMBL1264289,Antibacterial activity against Prevotella by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958007,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL4296592,Prevotella,Prevotella,838.0,,,MIC90,mg/L,UO_0000274,,32.0
67701,67701,,Non-toxic,3511047,[],CHEMBL1264290,"Toxicity against healthy human assessed as occurrence of urinary infection at 600 mg/kg, iv administered every 12 hrs for 7 days measured on day 9",T,,,BAO_0000375,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1255470,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,958007,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
67702,67702,,,3541980,[],CHEMBL1283212,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus expressing SCCmec type 4a element assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC90,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,ug ml-1,UO_0000274,,0.5
67703,67703,,,3541981,[],CHEMBL1283211,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus expressing SCCmec type 2 element by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67704,67704,,,3541982,[],CHEMBL1283214,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus expressing SCCmec type 2 element assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC90,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,ug ml-1,UO_0000274,,1.0
67705,67705,,,3541983,[],CHEMBL1283215,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67706,67706,,,3541985,[],CHEMBL1283213,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus expressing SCCmec type 4 element assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC90,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,ug ml-1,UO_0000274,,0.5
67707,67707,,,3541986,[],CHEMBL1283210,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus expressing SCCmec type 4 element by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67708,67708,,,3541987,[],CHEMBL1283209,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus expressing SCCmec type 4a element by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67709,67709,,,3541989,[],CHEMBL1283222,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC50,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,ug ml-1,UO_0000274,,0.5
67710,67710,,,3541991,[],CHEMBL1283224,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67711,67711,,,3541992,[],CHEMBL1284148,Antimicrobial activity against daptomycin-nonsusceptible Staphylococcus aureus by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67712,67712,,,3541993,[],CHEMBL1284153,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67713,67713,,,3541994,[],CHEMBL1284153,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67714,67714,,,3541996,[],CHEMBL1283220,Bactericidal activity against vancomycin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC50,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,ug ml-1,UO_0000274,,0.5
67715,67715,,,3541997,[],CHEMBL1284148,Antimicrobial activity against daptomycin-nonsusceptible Staphylococcus aureus by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.55,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.55
67716,67716,,,3541998,[],CHEMBL1284156,Bactericidal activity against daptomycin-nonsusceptible Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC,ug ml-1,,0.74,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.74
67717,67717,,,3541999,[],CHEMBL1283215,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67718,67718,,,3542003,[],CHEMBL1283222,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC90,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,ug ml-1,UO_0000274,,1.0
67719,67719,,,3542007,[],CHEMBL1283224,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67720,67720,,,3542008,[],CHEMBL1284146,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC50,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,ug ml-1,UO_0000274,,1.0
67721,67721,,,3542009,[],CHEMBL1284146,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC90,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,ug ml-1,UO_0000274,,1.0
67722,67722,,,3542010,[],CHEMBL1284156,Bactericidal activity against daptomycin-nonsusceptible Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC50,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,ug ml-1,UO_0000274,,1.0
67723,67723,,,3542012,[],CHEMBL1283220,Bactericidal activity against vancomycin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC90,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,ug ml-1,UO_0000274,,1.0
67724,67724,,,3543112,[],CHEMBL1284146,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.5
67725,67725,,,3543116,[],CHEMBL1284153,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
67726,67726,,,3543117,[],CHEMBL1283220,Bactericidal activity against vancomycin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC,ug ml-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.12
67727,67727,,,3543119,[],CHEMBL1283215,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67728,67728,,,3543121,[],CHEMBL1283222,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.25
67729,67729,,,3543122,[],CHEMBL1283224,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67730,67730,,,3543123,[],CHEMBL1284148,Antimicrobial activity against daptomycin-nonsusceptible Staphylococcus aureus by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67731,67731,,,3543124,[],CHEMBL1284156,Bactericidal activity against daptomycin-nonsusceptible Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.25
67732,67732,,,3543172,[],CHEMBL1282380,Antimicrobial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
67733,67733,,,3543177,[],CHEMBL1285085,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-7 expressing SCCmec element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
67734,67734,,,3543178,[],CHEMBL1285086,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-8 expressing SCCmec element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
67735,67735,,,3543179,[],CHEMBL1284166,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-26 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67736,67736,,,3543180,[],CHEMBL1284171,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-74 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67737,67737,,,3543181,[],CHEMBL1284172,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-76 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67738,67738,,,3543182,[],CHEMBL1285087,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-9 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67739,67739,,,3543183,[],CHEMBL1284159,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-4 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67740,67740,,,3543184,[],CHEMBL1284160,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-17 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67741,67741,,,3543185,[],CHEMBL1284161,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-18 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67742,67742,,,3543186,[],CHEMBL1284162,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-19 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67743,67743,,,3543187,[],CHEMBL1284163,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-22 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67744,67744,,,3543188,[],CHEMBL1284164,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-23 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67745,67745,,,3543189,[],CHEMBL1284165,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-24 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67746,67746,,,3543190,[],CHEMBL1284167,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-27 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67747,67747,,,3543191,[],CHEMBL1284169,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-68 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67748,67748,,,3543192,[],CHEMBL1284170,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-73 expressing SCCmec type 4d element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67749,67749,,,3543193,[],CHEMBL1284175,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-402 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67750,67750,,,3543194,[],CHEMBL1284176,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-403 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67751,67751,,,3543195,[],CHEMBL1284177,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-404 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67752,67752,,,3543196,[],CHEMBL1285080,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-2 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67753,67753,,,3543197,[],CHEMBL1285081,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-3 expressing SCCmec type 4 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67754,67754,,,3543198,[],CHEMBL1285082,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-4 expressing SCCmec type 4 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67755,67755,,,3543199,[],CHEMBL1285083,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-5 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67756,67756,,,3543200,[],CHEMBL1285084,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-6 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67757,67757,,,3543201,[],CHEMBL1282369,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-10 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67758,67758,,,3543210,[],CHEMBL1284158,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-3 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
67759,67759,,,3543211,[],CHEMBL1284168,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-51 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
67760,67760,,,3543212,[],CHEMBL1284173,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-118 expressing SCCmec type 1 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
67761,67761,,,3543213,[],CHEMBL1284174,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-126 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
67762,67762,,,3543214,[],CHEMBL1285079,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-1 expressing SCCmec type 2 element by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968628,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
67763,67763,,,3548093,[],CHEMBL1283828,Antibacterial activity against levofloxacin-resistant Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
67764,67764,,,3548097,[],CHEMBL1282938,Antibacterial activity against penicillin-nonsusceptible Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67765,67765,,,3548098,[],CHEMBL1282940,Antibacterial activity against amoxicillin-intermediate Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67766,67766,,,3548099,[],CHEMBL1282942,Antibacterial activity against amoxicillin-resistant Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67767,67767,,,3548100,[],CHEMBL1282944,Antibacterial activity against cefotaxime-intermediate Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67768,67768,,,3548101,[],CHEMBL1283700,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67769,67769,,,3548103,[],CHEMBL1283828,Antibacterial activity against levofloxacin-resistant Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.12
67770,67770,,,3548104,[],CHEMBL1282938,Antibacterial activity against penicillin-nonsusceptible Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67771,67771,,,3548105,[],CHEMBL1282940,Antibacterial activity against amoxicillin-intermediate Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67772,67772,,,3548106,[],CHEMBL1282942,Antibacterial activity against amoxicillin-resistant Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67773,67773,,,3548108,[],CHEMBL1282944,Antibacterial activity against cefotaxime-intermediate Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67774,67774,,,3548109,[],CHEMBL1283698,Antibacterial activity against cefotaxime-resistant Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
67775,67775,,,3548110,[],CHEMBL1283698,Antibacterial activity against cefotaxime-resistant Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67776,67776,,,3548111,[],CHEMBL1283700,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67777,67777,,,3548297,[],CHEMBL1283830,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67778,67778,,,3548298,[],CHEMBL1283830,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae isolate by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1275539,Antimicrob Agents Chemother,2008.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968967,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.12
67779,67779,,,5096226,[],CHEMBL1633112,Antimicrobial activity against Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67780,67780,,,5096232,[],CHEMBL1633112,Antimicrobial activity against Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67781,67781,,,5096988,[],CHEMBL1633112,Antimicrobial activity against Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67782,67782,,,5097051,[],CHEMBL1633104,Antimicrobial activity against Streptococcus pneumoniae R6 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
67783,67783,,,5097052,[],CHEMBL1633113,Antimicrobial activity against Streptococcus pneumoniae 3191 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
67784,67784,,,5097053,[],CHEMBL1633114,Antimicrobial activity against Streptococcus pneumoniae 72521 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
67785,67785,,,5097054,[],CHEMBL1633115,Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67786,67786,,,5097055,[],CHEMBL1633116,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2b, pbp1a and murM genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
67787,67787,,,5097056,[],CHEMBL1633111,Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
67788,67788,,,5097057,[],CHEMBL1633117,Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x and pbp1a genes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67789,67789,,,5097058,[],CHEMBL1633118,Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x and pbp2b genes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
67790,67790,,,5097059,[],CHEMBL1633119,Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x and pbp2b genes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67791,67791,,,5097060,[],CHEMBL1633120,Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x and Streptococcus pneumoniae 72521 pbp2b genes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67792,67792,,,5097061,[],CHEMBL1633121,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x, pbp1a and pbp2b genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
67793,67793,,,5097062,[],CHEMBL1633122,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x, pbp2b and Streptococcus pneumoniae 3191 pbp1a genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67794,67794,,,5097063,[],CHEMBL1633123,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 genomic DNA, pbp2x, pbp1a and pbp2b genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67795,67795,,,5097064,[],CHEMBL1633124,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x, pbp1a, pbp2b genes and Streptococcus pneumoniae 3191 genomic DNA by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
67796,67796,,,5097065,[],CHEMBL1633125,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 pbp2x, pbp1a, pbp2b and Streptococcus pneumoniae 3191 murM genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
67797,67797,,,5097066,[],CHEMBL1633126,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x, pbp2b, murM and Streptococcus pneumoniae 72521 pbp1a genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67798,67798,,,5097067,[],CHEMBL1633127,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 genomic DNA, pbp2x, pbp1a, pbp2b and Streptococcus pneumoniae 3191 pbp1a genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67799,67799,,,5097068,[],CHEMBL1636656,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 72521 murM, pbp2x, pbp2b and Streptococcus pneumoniae 3191 pbp1a genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
67800,67800,,,5097069,[],CHEMBL1636657,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x, pbp2b, pbp1a and Streptococcus pneumoniae 72521 murM genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
67801,67801,,,5097070,[],CHEMBL1636658,"Antimicrobial activity against Streptococcus pneumoniae R6 transformed with Streptococcus pneumoniae 3191 pbp2x, pbp2b, pbp1a genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629597,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315066,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
67802,67802,,,5097337,[],CHEMBL1637974,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67803,67803,,,5097338,[],CHEMBL1637975,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67804,67804,,,5097339,[],CHEMBL1637976,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
67805,67805,,,5097340,[],CHEMBL1637977,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
67806,67806,,,5097341,[],CHEMBL1637978,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.12
67807,67807,,,5097342,[],CHEMBL1637979,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.03
67808,67808,,,5097343,[],CHEMBL1637980,Antimicrobial activity against Enterococcus faecalis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.12
67809,67809,,,5097344,[],CHEMBL1637981,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
67810,67810,,,5097345,[],CHEMBL1637982,Antimicrobial activity against Enterococcus faecium by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
67811,67811,,,5097346,[],CHEMBL1637983,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.015
67812,67812,,,5097347,[],CHEMBL1637984,Antimicrobial activity against Corynebacterium jeikeium by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,,MIC,ug ml-1,UO_0000274,,0.12
67813,67813,,,5097348,[],CHEMBL1637985,Antimicrobial activity against Listeria monocytogenes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,2.0
67814,67814,,,5097349,[],CHEMBL1637986,Antimicrobial activity against Streptococcus agalactiae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.015
67815,67815,,,5097350,[],CHEMBL1637987,Antimicrobial activity against levofloxacin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
67816,67816,,,5097351,[],CHEMBL1637988,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
67817,67817,,,5097352,[],CHEMBL1637989,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
67818,67818,,,5097353,[],CHEMBL1637990,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
67819,67819,,,5097354,[],CHEMBL1637991,Antimicrobial activity against macrolide-resistant Streptococcus pyogenes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.015
67820,67820,,,5097355,[],CHEMBL1637992,Antimicrobial activity against macrolide-susceptible Streptococcus pyogenes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.015
67821,67821,,,5097356,[],CHEMBL1637993,Antimicrobial activity against Streptococcus viridans group clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,0.015
67822,67822,,,5097357,[],CHEMBL1637994,Antimicrobial activity against ESBL-negative Enterobacter aerogenes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.03
67823,67823,,,5097358,[],CHEMBL1637995,Antimicrobial activity against ESBL-negative Enterobacter cloacae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.06
67824,67824,,,5097359,[],CHEMBL1637996,Antimicrobial activity against ESBL-negative Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
67825,67825,,,5097360,[],CHEMBL1637997,Antimicrobial activity against ESBL-positive Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
67826,67826,,,5097361,[],CHEMBL1637998,Antimicrobial activity against ESBL-negative Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
67827,67827,,,5097362,[],CHEMBL1637999,Antimicrobial activity against ESBL-positive Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
67828,67828,,,5097363,[],CHEMBL1638000,Antimicrobial activity against Morganella morganii by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.06
67829,67829,,,5097364,[],CHEMBL1638001,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.03
67830,67830,,,5097365,[],CHEMBL1638002,Antimicrobial activity against Proteus rettgeri by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.03
67831,67831,,,5097366,[],CHEMBL1636122,Antimicrobial activity against Proteus stuartii by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,,MIC,ug ml-1,UO_0000274,,0.06
67832,67832,,,5097367,[],CHEMBL1636123,Antimicrobial activity against Proteus vulgaris by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.03
67833,67833,,,5097368,[],CHEMBL1636124,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.5
67834,67834,,,5097369,[],CHEMBL1636125,Antimicrobial activity against Shigella spp. by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614397,Shigella sp.,Shigella sp.,625.0,,,MIC,ug ml-1,UO_0000274,,0.015
67835,67835,,,5097370,[],CHEMBL1636126,Antimicrobial activity against Salmonella spp. by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612618,Salmonella sp.,Salmonella sp.,599.0,,,MIC,ug ml-1,UO_0000274,,0.06
67836,67836,,,5097371,[],CHEMBL1636127,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,ug ml-1,UO_0000274,,0.03
67837,67837,,,5097372,[],CHEMBL1636128,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
67838,67838,,,5097373,[],CHEMBL1636129,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
67839,67839,,,5097374,[],CHEMBL1636130,Antimicrobial activity against Stenotrophomonas maltophilia by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,0.12
67840,67840,,,5097375,[],CHEMBL1636131,Antimicrobial activity against Moraxella catarrhalis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.015
67841,67841,,,5097376,[],CHEMBL1636132,Antimicrobial activity against beta-lactamase-negative Haemophilus influenzae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.015
67842,67842,,,5097377,[],CHEMBL1636133,Antimicrobial activity against beta-lactamase-positive Haemophilus influenzae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.015
67843,67843,,,5097378,[],CHEMBL1636134,Antimicrobial activity against beta-lactamase-negative ampicillin resistant Haemophilus influenzae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.015
67844,67844,,,5097505,[],CHEMBL1637974,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67845,67845,,,5097506,[],CHEMBL1637975,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
67846,67846,,,5097507,[],CHEMBL1637976,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,1.0
67847,67847,,,5097508,[],CHEMBL1637978,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.25
67848,67848,,,5097509,[],CHEMBL1637979,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.06
67849,67849,,,5097510,[],CHEMBL1637980,Antimicrobial activity against Enterococcus faecalis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,2.0
67850,67850,,,5097511,[],CHEMBL1637981,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,1.0
67851,67851,,,5097512,[],CHEMBL1637982,Antimicrobial activity against Enterococcus faecium by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,32.0
67852,67852,,,5097513,[],CHEMBL1637983,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,1.0
67853,67853,,,5097514,[],CHEMBL1637984,Antimicrobial activity against Corynebacterium jeikeium by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,,MIC50,ug ml-1,UO_0000274,,32.0
67854,67854,,,5097515,[],CHEMBL1637985,Antimicrobial activity against Listeria monocytogenes by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC50,ug ml-1,UO_0000274,,4.0
67855,67855,,,5097516,[],CHEMBL1637986,Antimicrobial activity against Streptococcus agalactiae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67856,67856,,,5097517,[],CHEMBL1637987,Antimicrobial activity against levofloxacin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
67857,67857,,,5097518,[],CHEMBL1637988,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
67858,67858,,,5097519,[],CHEMBL1637989,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
67859,67859,,,5097520,[],CHEMBL1637990,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67860,67860,,,5097521,[],CHEMBL1637991,Antimicrobial activity against macrolide-resistant Streptococcus pyogenes by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67861,67861,,,5097522,[],CHEMBL1637992,Antimicrobial activity against macrolide-susceptible Streptococcus pyogenes by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67862,67862,,,5097523,[],CHEMBL1637993,Antimicrobial activity against Streptococcus viridans group clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67863,67863,,,5097524,[],CHEMBL1637994,Antimicrobial activity against ESBL-negative Enterobacter aerogenes by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67864,67864,,,5097525,[],CHEMBL1637995,Antimicrobial activity against ESBL-negative Enterobacter cloacae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67865,67865,,,5097526,[],CHEMBL1637996,Antimicrobial activity against ESBL-negative Escherichia coli by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,0.06
67866,67866,,,5097527,[],CHEMBL1637997,Antimicrobial activity against ESBL-positive Escherichia coli by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,32.0
67867,67867,,,5097528,[],CHEMBL1637998,Antimicrobial activity against ESBL-negative Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,0.06
67868,67868,,,5097529,[],CHEMBL1637999,Antimicrobial activity against ESBL-positive Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,32.0
67869,67869,,,5097530,[],CHEMBL1638000,Antimicrobial activity against Morganella morganii by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC50,ug ml-1,UO_0000274,,32.0
67870,67870,,,5097531,[],CHEMBL1638001,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,0.06
67871,67871,,,5097532,[],CHEMBL1638002,Antimicrobial activity against Proteus rettgeri by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC50,ug ml-1,UO_0000274,,1.0
67872,67872,,,5097533,[],CHEMBL1636122,Antimicrobial activity against Proteus stuartii by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,,MIC50,ug ml-1,UO_0000274,,1.0
67873,67873,,,5097534,[],CHEMBL1636123,Antimicrobial activity against Proteus vulgaris by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC50,ug ml-1,UO_0000274,,16.0
67874,67874,,,5097535,[],CHEMBL1636124,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC50,ug ml-1,UO_0000274,,0.5
67875,67875,,,5097536,[],CHEMBL1636125,Antimicrobial activity against Shigella spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614397,Shigella sp.,Shigella sp.,625.0,,,MIC50,ug ml-1,UO_0000274,,0.03
67876,67876,,,5097537,[],CHEMBL1636126,Antimicrobial activity against Salmonella spp. by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL612618,Salmonella sp.,Salmonella sp.,599.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67877,67877,,,5097538,[],CHEMBL1636127,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC50,ug ml-1,UO_0000274,,32.0
67878,67878,,,5097539,[],CHEMBL1636128,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,16.0
67879,67879,,,5097540,[],CHEMBL1636129,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,16.0
67880,67880,,,5097541,[],CHEMBL1636130,Antimicrobial activity against Stenotrophomonas maltophilia by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC50,ug ml-1,UO_0000274,,32.0
67881,67881,,,5097542,[],CHEMBL1636131,Antimicrobial activity against Moraxella catarrhalis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67882,67882,,,5097543,[],CHEMBL1636132,Antimicrobial activity against beta-lactamase-negative Haemophilus influenzae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67883,67883,,,5097544,[],CHEMBL1636133,Antimicrobial activity against beta-lactamase-positive Haemophilus influenzae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.015
67884,67884,,,5097545,[],CHEMBL1636134,Antimicrobial activity against beta-lactamase-negative ampicillin resistant Haemophilus influenzae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.12
67885,67885,,,5098011,[],CHEMBL1637974,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67886,67886,,,5098012,[],CHEMBL1637975,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67887,67887,,,5098013,[],CHEMBL1637976,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67888,67888,,,5098014,[],CHEMBL1637978,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67889,67889,,,5098015,[],CHEMBL1637979,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67890,67890,,,5098016,[],CHEMBL1637980,Antimicrobial activity against Enterococcus faecalis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,4.0
67891,67891,,,5098017,[],CHEMBL1637981,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,4.0
67892,67892,,,5098018,[],CHEMBL1637982,Antimicrobial activity against Enterococcus faecium by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67893,67893,,,5098019,[],CHEMBL1637983,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
67894,67894,,,5098020,[],CHEMBL1637984,Antimicrobial activity against Corynebacterium jeikeium by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67895,67895,,,5098021,[],CHEMBL1637985,Antimicrobial activity against Listeria monocytogenes by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC90,ug ml-1,UO_0000274,,4.0
67896,67896,,,5098022,[],CHEMBL1637986,Antimicrobial activity against Streptococcus agalactiae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.015
67897,67897,,,5098023,[],CHEMBL1637987,Antimicrobial activity against levofloxacin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67898,67898,,,5098024,[],CHEMBL1637988,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67899,67899,,,5098025,[],CHEMBL1637989,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.06
67900,67900,,,5098026,[],CHEMBL1637990,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.015
67901,67901,,,5098027,[],CHEMBL1637991,Antimicrobial activity against macrolide-resistant Streptococcus pyogenes by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.015
67902,67902,,,5098028,[],CHEMBL1637992,Antimicrobial activity against macrolide-susceptible Streptococcus pyogenes by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.015
67903,67903,,,5098029,[],CHEMBL1637993,Antimicrobial activity against Streptococcus viridans group clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,ug ml-1,UO_0000274,,0.12
67904,67904,,,5098030,[],CHEMBL1637994,Antimicrobial activity against ESBL-negative Enterobacter aerogenes by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67905,67905,,,5098031,[],CHEMBL1637995,Antimicrobial activity against ESBL-negative Enterobacter cloacae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,0.5
67906,67906,,,5098032,[],CHEMBL1637996,Antimicrobial activity against ESBL-negative Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,1.0
67907,67907,,,5098033,[],CHEMBL1637997,Antimicrobial activity against ESBL-positive Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67908,67908,,,5098034,[],CHEMBL1637998,Antimicrobial activity against ESBL-negative Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67909,67909,,,5098035,[],CHEMBL1637999,Antimicrobial activity against ESBL-positive Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67910,67910,,,5098036,[],CHEMBL1638000,Antimicrobial activity against Morganella morganii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67911,67911,,,5098037,[],CHEMBL1638001,Antimicrobial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,4.0
67912,67912,,,5098038,[],CHEMBL1638002,Antimicrobial activity against Proteus rettgeri by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC90,ug ml-1,UO_0000274,,4.0
67913,67913,,,5098039,[],CHEMBL1636122,Antimicrobial activity against Proteus stuartii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,,MIC90,ug ml-1,UO_0000274,,4.0
67914,67914,,,5098040,[],CHEMBL1636123,Antimicrobial activity against Proteus vulgaris by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67915,67915,,,5098041,[],CHEMBL1636124,Antimicrobial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,8.0
67916,67916,,,5098042,[],CHEMBL1636125,Antimicrobial activity against Shigella spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614397,Shigella sp.,Shigella sp.,625.0,,,MIC90,ug ml-1,UO_0000274,,0.12
67917,67917,,,5098043,[],CHEMBL1636126,Antimicrobial activity against Salmonella spp. by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL612618,Salmonella sp.,Salmonella sp.,599.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67918,67918,,,5098044,[],CHEMBL1636127,Antimicrobial activity against Burkholderia cepacia by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67919,67919,,,5098045,[],CHEMBL1636128,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67920,67920,,,5098046,[],CHEMBL1636129,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67921,67921,,,5098047,[],CHEMBL1636130,Antimicrobial activity against Stenotrophomonas maltophilia by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,32.0
67922,67922,,,5098048,[],CHEMBL1636131,Antimicrobial activity against Moraxella catarrhalis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67923,67923,,,5098049,[],CHEMBL1636132,Antimicrobial activity against beta-lactamase-negative Haemophilus influenzae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.015
67924,67924,,,5098050,[],CHEMBL1636133,Antimicrobial activity against beta-lactamase-positive Haemophilus influenzae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.06
67925,67925,,,5098051,[],CHEMBL1636134,Antimicrobial activity against beta-lactamase-negative ampicillin resistant Haemophilus influenzae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315577,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.25
67926,67926,,,5098175,[],CHEMBL1636135,fT>MIC Streptococcus pneumoniae infected mouse model for 1-log kill,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,1315577,=,1,0,=,,fT>MIC,%,,43.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,43.0
67927,67927,,,5098176,[],CHEMBL1636136,fT>MIC Staphylococcus aureus infected mouse model for 1-log kill,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,1315577,=,1,0,=,,fT>MIC,%,,33.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,33.0
67928,67928,,,5098177,[],CHEMBL1636137,fT>MIC Enterobacteriaceae infected mouse model for 1-log kill,F,,,BAO_0000179,BAO_0000019,assay format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1629657,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,1315577,=,1,0,=,,fT>MIC,%,,41.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fT>MIC,%,UO_0000187,,41.0
67929,67929,,Not Active,5146216,[],CHEMBL1666707,Bactericidal activity against Klebsiella pneumoniae isolate 5427 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,1326474,,1,0,,,Inhibition,%,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,INH,,UO_0000187,,
67930,67930,,Not Active,5146223,[],CHEMBL1666708,Bactericidal activity against Klebsiella pneumoniae isolate 5436 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,1326474,,1,0,,,Inhibition,%,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,INH,,UO_0000187,,
67931,67931,,Not Active,5146230,[],CHEMBL1666709,Bactericidal activity against Escherichia coli isolate 5401 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,1326474,,1,0,,,Inhibition,%,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,INH,,UO_0000187,,
67932,67932,,Not Active,5146237,[],CHEMBL1666710,Bactericidal activity against Escherichia coli isolate 5411 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://qudt.org/vocab/unit#Percent,1326474,,1,0,,,Inhibition,%,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,INH,,UO_0000187,,
67933,67933,,,5146244,[],CHEMBL1666711,Antimicrobial activity against Escherichia coli expressing beta-lactamase inhibitor CTX-M by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
67934,67934,,,5146245,[],CHEMBL1666712,Antimicrobial activity against Escherichia coli expressing beta-lactamase inhibitor TEM-1 by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/ml,UO_0000274,,2.0
67935,67935,,,5146246,[],CHEMBL1666713,Antimicrobial activity against Escherichia coli expressing beta-lactamase inhibitor TEM-2 by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/ml,UO_0000274,,2.0
67936,67936,,,5146247,[],CHEMBL1666714,Antimicrobial activity against Escherichia coli expressing beta-lactamase inhibitor SHV-1 by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/ml,UO_0000274,,2.0
67937,67937,,,5146248,[],CHEMBL1666715,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase inhibitor CTX-M by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,128.0
67938,67938,,,5146249,[],CHEMBL1666716,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase inhibitor TEM-1 by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,2000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/ml,UO_0000274,,2.0
67939,67939,,,5146250,[],CHEMBL1666717,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase inhibitor TEM-2 by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,2000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/ml,UO_0000274,,2.0
67940,67940,,,5146251,[],CHEMBL1666718,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase inhibitor SHV-1 by agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,2000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/ml,UO_0000274,,2.0
67941,67941,,,5146252,[],CHEMBL1666719,Bactericidal activity against Pseudomonas aeruginosa isolate 796 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.12
67942,67942,,,5146253,[],CHEMBL1666720,Bactericidal activity against Pseudomonas aeruginosa isolate 956 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.08,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.08
67943,67943,,,5146254,[],CHEMBL1666721,Bactericidal activity against Pseudomonas aeruginosa isolate 1019 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.02,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.02
67944,67944,,,5146255,[],CHEMBL1666722,Bactericidal activity against Pseudomonas aeruginosa isolate 1037 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.01,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.01
67945,67945,,,5146256,[],CHEMBL1666723,Bactericidal activity against Enterobacter cloacae isolate 4073 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.57,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,log10CFU/ml,,,,0.57
67946,67946,,,5146257,[],CHEMBL1666724,Bactericidal activity against Enterobacter cloacae isolate 5420 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.14,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,log10CFU/ml,,,,0.14
67947,67947,,,5146258,[],CHEMBL1666725,Bactericidal activity against Klebsiella pneumoniae isolate 5427 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,1.13,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,log10CFU/ml,,,,1.13
67948,67948,,,5146259,[],CHEMBL1666726,Bactericidal activity against Klebsiella pneumoniae isolate 5436 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.48,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,log10CFU/ml,,,,0.48
67949,67949,,,5146260,[],CHEMBL1666861,Bactericidal activity against Escherichia coli isolate 5401 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.94,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/ml,,,,0.94
67950,67950,,,5146261,[],CHEMBL1666862,Bactericidal activity against Escherichia coli isolate 5411 at 1/4 times MIC after 2 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.66,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/ml,,,,0.66
67951,67951,,,5146262,[],CHEMBL1667554,Bactericidal activity against Pseudomonas aeruginosa isolate 796 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.32,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.32
67952,67952,,,5146263,[],CHEMBL1667555,Bactericidal activity against Pseudomonas aeruginosa isolate 956 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.01,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.01
67953,67953,,,5146264,[],CHEMBL1667556,Bactericidal activity against Pseudomonas aeruginosa isolate 1019 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.43,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.43
67954,67954,,,5146265,[],CHEMBL1667557,Bactericidal activity against Pseudomonas aeruginosa isolate 1037 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.06
67955,67955,,,5146266,[],CHEMBL1667558,Bactericidal activity against Enterobacter cloacae isolate 4073 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.65,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,log10CFU/ml,,,,0.65
67956,67956,,,5146267,[],CHEMBL1667559,Bactericidal activity against Enterobacter cloacae isolate 5420 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.43,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,log10CFU/ml,,,,0.43
67957,67957,,,5146268,[],CHEMBL1667560,Bactericidal activity against Klebsiella pneumoniae isolate 5427 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,2.78,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,log10CFU/ml,,,,2.78
67958,67958,,,5146269,[],CHEMBL1667561,Bactericidal activity against Klebsiella pneumoniae isolate 5436 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,2.92,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,log10CFU/ml,,,,2.92
67959,67959,,,5146270,[],CHEMBL1667562,Bactericidal activity against Escherichia coli isolate 5401 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/ml,,,,2.0
67960,67960,,,5146271,[],CHEMBL1667563,Bactericidal activity against Escherichia coli isolate 5411 at 1/4 times MIC after 4 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,2.43,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/ml,,,,2.43
67961,67961,,,5146272,[],CHEMBL1667564,Bactericidal activity against Pseudomonas aeruginosa isolate 796 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.08,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.08
67962,67962,,,5146273,[],CHEMBL1667565,Bactericidal activity against Pseudomonas aeruginosa isolate 956 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.51,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.51
67963,67963,,,5146274,[],CHEMBL1667566,Bactericidal activity against Pseudomonas aeruginosa isolate 1019 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.95,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.95
67964,67964,,,5146275,[],CHEMBL1667567,Bactericidal activity against Pseudomonas aeruginosa isolate 1037 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.73,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.73
67965,67965,,,5146276,[],CHEMBL1667568,Bactericidal activity against Enterobacter cloacae isolate 4073 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.83,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,log10CFU/ml,,,,0.83
67966,67966,,,5146277,[],CHEMBL1667569,Bactericidal activity against Enterobacter cloacae isolate 5420 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.29,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,log10CFU/ml,,,,0.29
67967,67967,,,5146278,[],CHEMBL1667570,Bactericidal activity against Klebsiella pneumoniae isolate 5427 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,4.89,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,log10CFU/ml,,,,4.89
67968,67968,,,5146279,[],CHEMBL1667571,Bactericidal activity against Klebsiella pneumoniae isolate 5436 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,5.31,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,log10CFU/ml,,,,5.31
67969,67969,,,5146280,[],CHEMBL1667572,Bactericidal activity against Escherichia coli isolate 5401 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,3.37,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/ml,,,,3.37
67970,67970,,,5146281,[],CHEMBL1667573,Bactericidal activity against Escherichia coli isolate 5411 at 1/4 times MIC after 8 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,3.79,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/ml,,,,3.79
67971,67971,,,5146282,[],CHEMBL1667574,Bactericidal activity against Pseudomonas aeruginosa isolate 796 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.31,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.31
67972,67972,,,5146283,[],CHEMBL1667575,Bactericidal activity against Pseudomonas aeruginosa isolate 956 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.52,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.52
67973,67973,,,5146284,[],CHEMBL1667576,Bactericidal activity against Pseudomonas aeruginosa isolate 1019 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,1.22,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,1.22
67974,67974,,,5146285,[],CHEMBL1667577,Bactericidal activity against Pseudomonas aeruginosa isolate 1037 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10CFU/ml,,,,0.56
67975,67975,,,5146286,[],CHEMBL1667578,Bactericidal activity against Enterobacter cloacae isolate 4073 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.47,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,log10CFU/ml,,,,0.47
67976,67976,,,5146287,[],CHEMBL1667579,Bactericidal activity against Enterobacter cloacae isolate 5420 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,0.46,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,log10CFU/ml,,,,0.46
67977,67977,,,5146288,[],CHEMBL1667580,Bactericidal activity against Klebsiella pneumoniae isolate 5427 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,5.27,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,log10CFU/ml,,,,5.27
67978,67978,,,5146289,[],CHEMBL1664945,Bactericidal activity against Klebsiella pneumoniae isolate 5436 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,5.62,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,log10CFU/ml,,,,5.62
67979,67979,,,5146290,[],CHEMBL1664946,Bactericidal activity against Escherichia coli isolate 5401 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,4.99,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/ml,,,,4.99
67980,67980,,,5146291,[],CHEMBL1664947,Bactericidal activity against Escherichia coli isolate 5411 at 1/4 times MIC after 24 hrs by time kill analysis in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,,1326474,=,1,0,=,,log10CFU/ml,,,6.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/ml,,,,6.02
67981,67981,,,5153354,[],CHEMBL1666521,Antimicrobial activity against ESBL-producing Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
67982,67982,,,5153361,[],CHEMBL1666522,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
67983,67983,,,5153368,[],CHEMBL1666523,Antimicrobial activity against AmpC-depressed Enterobacter cloacae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.125
67984,67984,,,5153375,[],CHEMBL1666524,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
67985,67985,,,5153382,[],CHEMBL1666525,Antimicrobial activity against ESBL-producing Escherichia coli by broth microdilution method in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
67986,67986,,,5153383,[],CHEMBL1666526,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae by broth microdilution method in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
67987,67987,,,5153384,[],CHEMBL1666527,Antimicrobial activity against Enterobacter cloacae by broth microdilution method in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.125
67988,67988,,,5153385,[],CHEMBL1666528,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
67989,67989,,,5153386,[],CHEMBL1666521,Antimicrobial activity against ESBL-producing Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,4.0
67990,67990,,,5153393,[],CHEMBL1666522,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,0,=,,MBC,ug ml-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,ug ml-1,UO_0000274,,32.0
67991,67991,,,5153400,[],CHEMBL1666523,Antimicrobial activity against AmpC-depressed Enterobacter cloacae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MBC,ug ml-1,UO_0000274,,0.125
67992,67992,,,5153407,[],CHEMBL1666524,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,0,=,,MBC,ug ml-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,16.0
67993,67993,,,5153414,[],CHEMBL1666525,Antimicrobial activity against ESBL-producing Escherichia coli by broth microdilution method in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
67994,67994,,,5153415,[],CHEMBL1666526,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae by broth microdilution method in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,ug ml-1,UO_0000274,,1.0
67995,67995,,,5153416,[],CHEMBL1666527,Antimicrobial activity against Enterobacter cloacae by broth microdilution method in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MBC,ug ml-1,UO_0000274,,0.125
67996,67996,,,5153417,[],CHEMBL1666528,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0000179,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,0,=,,MBC,ug ml-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,16.0
67997,67997,,,5153418,[],CHEMBL1666529,Antimicrobial activity against Escherichia coli isolate 5401 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
67998,67998,,,5153425,[],CHEMBL1666530,Antimicrobial activity against Escherichia coli isolate 5411 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
67999,67999,,,5153432,[],CHEMBL1666683,Antimicrobial activity against Escherichia coli isolate 5401 by broth microdilution method in presence of 4 ug/ml beta-lactamase inhibitor Tazobactam,F,,,BAO_0002146,BAO_0000218,organism-based format,CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(Sc3nc(-c4cc[n+](C)cc4)cs3)CS[C@H]12)c1nsc(NP(=O)(O)O)n1,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL501122,CEFTAROLINE FOSAMIL,CHEMBL501122,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326474,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
